生合生物科技有限公司Press Release

生合生物科技有限公司Press Releasehttps://www.synbiotech.com/En生合生物科技有限公司Press Releasezh-twFri, 13 Mar 2026 16:46:00 GMTSynbioTech Wins 5 Gold Medals at US Innovation Awards as as 'Symbiotic Fermentation' Boosts Probiotic Potency Over 50%https://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=b45b1896-c127-4cc8-a296-9a2efd5101b1ABKEFIR® Boosts Probiotic Strength Over 50% by “Symbiotic Fermentation” SynbioTech INC., ranked among the top 20 global probiotic suppliers, proudly announced a significant triumph at the 2025 AII DaVinci International Innovation and Invention Expo. The company won five Gold Medals for its pioneering probiotic and postbiotic solutions. SynbioTech’s scientifically validated breakthroughs in precision health earned high acclaim from the international panel of judges. The award-winning innovations include: ‧ABKEFIR®: Developed using a proprietary “symbiotic fermentation” process, the innovative technology is verified to enhance antioxidant capacity, modulate immune response, and demonstrates a potent inhibitory effect against the common foodborne pathogen Salmonella typhimurium. ‧LDL557 Postbiotic: A novel solution proven to mitigate joint swelling, prevent cartilage matrix damage, and alleviate inflammatory responses. ‧SynForU®-ReMain: An advanced formula that utilizes the gut-kidney axis mechanism to provide adjunctive support for managing chronic kidney disease.The 6th Annual AII DaVinci International Innovation and Invention Expo, co-hosted by the American Innovation & Invention Institute and Southern Utah University in 2025, is a prestigious platform for global innovation, attracting participants from over ten countries, including the United States, Taiwan, China, Thailand, and Canada. SynbioTech Innovations in Precision Health for an Aging Population SynbioTech possesses one of Asia’s largest commercial lactic acid bacteria strain banks, with a collection exceeding 2,000 strains. “We are honored by this recognition from the Da Vinci Expo. As we believe that better probiotics make our lives better, the R&D team at SynbioTech has grown swiftly and focused on cutting-edge developments in functional probiotics." Said Mr. Yang Lian-Chuan, President of SynbioTech. " Those award-winning health products are scientifically proven to help boost immunity, protect joints, and support kidney health for the aging population." SYNTEK® Thorough Enhances Probiotic Potency by Over 50% Mr. Sean Yang, COO of SynbioTech, highlighted a key innovation: "SynbioTech's ABKEFIR®, developed by our proprietary SYNTEK® thorough procedure, combines five selected lactic acid strains from traditional kefir with two dominant gut bacteria. The breakthrough technology of 'Symbiotic Fermentation' increases the stability and concentration of probiotics by over 50%. Furthermore, human clinical trials have confirmed its effectiveness in regulating gut microbiota and alleviating gastrointestinal discomfort." Another gold-medal highlight was the formula’s proven ability to inhibit harmful bacteria like Salmonella, a leading cause of fatal food poisoning worldwide according to the U.S. Centers for Disease Control and Prevention (CDC). This innovation is protected by patents in Taiwan (I854384) and the United States (US11839635B1). SynbioTech’s Global Strategy for Acclaimed Products ABKEFIR®, SynForU®-ReMain, and LDL557 are award-winning probiotics with significant global appeal, expanding their market presence across Greater China, North America, Europe, and the Asia-Pacific region to serve aging populations. SynForU®-ReMain, in particular, addresses the unique nutritional needs of dialysis patients and seniors, with demand for renal health supplements rapidly rising in both the US and South Korea. COO Sean Yang said, "The company plans to accelerate its expansion into the Pacific Rim, focusing on active aging demographics in Southeast Asia, Australia, and South Asia." Established in 2000, SynbioTech INC. excels in microbial technology and probiotic research. Based in Taiwan, SynbioTech supplies over half of the local health food brands and collaborates with major international partners in the US, Germany, Korea, and Australia. The company holds 60 patents and has published over 100 scientific papers, nearly half of which appeared in peer-reviewed journals. <a href="https://www.synbiotech.com/EN/">Please check SynbioTech official website.</a> Media Contact Rica Chiang Director of Public Relations +886-7-6955680 EXT 2216 <a href="mailto:rica.chiang@synbiotech.com.tw">rica.chiang@synbiotech.com.tw</a> <img alt="" src="/ckfinder/userfiles/Images/SynbioTech%20participated%20in%20the%20US%20Da%20Vinci%20International%20Invention%20Exhibition_%20Studies%20show%20that%20ABKEFIR%c2%ae.png" style="width: 100%; height: 100%;" /> SynbioTech participated in the US Da Vinci International Invention Exhibition. Studies show that ABKEFIR®, using ‘symbiotic fermentation’ technology, offers superior antibacterial effects compared to single strains, enhancing its gut health benefits. <a href="https://apnews.com/press-release/pr-newswire/synbiotech-wins-5-gold-medals-at-us-innovation-awards-3bd76600b8a6ca5d63236b9ba1526d74">AP NEWS</a> <a href="https://finance.yahoo.com/news/synbiotech-wins-5-gold-medals-010000505.html?guccounter=1">YAHOO FINANCE</a> <a href="http://indiatoday.in/pr-newswire?rkey=20251217AE49644&filter=4315">India Today</a> <a href="https://au.finance.yahoo.com/news/synbiotech-wins-5-gold-medals-010000505.html">Australia Yahoo finance</a>  生合生物科技有限公司Thu, 18 Dec 2025 00:00:00 GMTSynbioTech Brings Taiwan’s Biotech Excellence to the Global Stage with TWK10® for Muscle Performance and Healthy Aginghttps://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=d3c9e4df-0cd3-42c6-9d09-57228bc6e213<div style="text-align: justify;"><img alt="" src="/ckfinder/userfiles/Images/20251016-Supplyside%20global%20%e6%96%b0%e8%81%9e%e7%a8%bf%e7%85%a7%e7%89%87.jpg" style="width: 100%; height: 100%;" /> In a field where scientific validation defines credibility, Synbio Tech Inc., a biotechnology company from Taiwan, is gaining international recognition with its proprietary probiotic Lactiplantibacillus plantarum TWK10®. The clinically proven strain, which will be featured at SupplySide Global 2025 from October 27–30 (Booth #6253F), has shown measurable benefits on muscle strength, endurance, and balance—offering a new microbiome-based approach to healthy aging and active living. Backed by over a decade of research, TWK10® has been evaluated in peer-reviewed human clinical studies, demonstrating proven benefits in both active individuals and older adults. Clinical findings show that TWK10® boosts endurance performance by 20-40% and increases muscle mass by 0.5-1 kg, while improving overall strength, recovery, and mobility across life stages. One of these landmark studies was recognized by Wiley as a “Top Cited Article,” underscoring TWK10®'s scientific impact and its growing influence in gut–muscle axis research. TWK10® has earned strong credibility and recognition across global regulatory frameworks, including U.S. GRAS Self-Affirmed status, Korea’s Health Functional Food approval, Taiwan’s Health Food certification with an anti-fatigue claim, Malaysia’s MAL registration, and Thailand’s probiotic listing.  The recent Japan FFC authorization marks another milestone, positioning TWK10® among the most clinically and regulatorily validated probiotics for muscle health worldwide. Together with a growing portfolio of real-world data, these achievements reinforce SynbioTech’s reputation as a science-driven innovator delivering microbiome-based health solutions through probiotics and postbiotics. “For SynbioTech, it’s more than a product story—it’s about proving how microbiome science can truly enhance daily life,” said Chuan-Hsien Yang, Chief Operating Officer at SynbioTech. “TWK10® is the result of years of research that bridge traditional fermentation knowledge from Taiwan with modern clinical science.” SynbioTech continues to expand its global partnerships and research collaborations, reflecting a broader vision to connect Asian innovation with global health markets and empower people to live healthier through microbiome science. About Synbio Tech Inc. Founded in 2000, Synbio Tech is a global biotechnology company specializing in probiotics, postbiotics, and microbiome-based health solutions. With over 25 years of R&D experience and a fully integrated CDMO platform, the company partners with more than 600 brands across 35 countries to deliver “From Strain to Solution” innovations that change lives with probiotics. 🌐 www.synbiotech.com  </div> 生合生物科技有限公司Fri, 17 Oct 2025 00:00:00 GMTSynbioTech's TWK10 Approved to Boost Muscle Strength, The Probiotic Pioneer Marches Toward Southeast Asia Markethttps://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=dd0f73e1-9a8c-46d1-865e-9dc401dbb4b8<img alt="" src="/ckfinder/userfiles/Images/S__18030606(1).jpg" style="width: 100%; height: 100%;" /> <div style="text-align: justify;"> SynbioTech Inc., ranked among the world’s top 20 probiotic suppliers, is the leaders in developing functional probiotics for muscle and joint health in seniors, sports, women’s wellness, and immune support., Its patented flagship probiotic, Lactiplantibacillus plantarum TWK10®, has earned multiple awards in Europe, the US and Japan, with clinical trials showing increasedcertificates in muscle massgain, and reduced body fat significantly decreased. In 2024, TWK10®Recently  was approved by the Thai government as an edible strain,, TWK10® has become one of making it a high key focus in the Thai market. SynbioTech will further showcase its this and other star flagship probiotics products  at Vitafoods Asia 2025 in Bangkok ( from September 17-19 (, Booth B27), demonstrating highlighting multifunctional precision health benefits.   Sean Yang (Yang, Chuan-Hsien), General Manager of SynbioTech Inc., highlights TWK10®'s prestigious accolades, including the 2025 Vitafoods Europe Innovation Awards top prize in‘Sports Nutrition and Healthy Living’, US GRAS ( Generally Recognized As Safe ) certification, and the Gold Medal at the 2025 Tokyo Invention Expo. Sean mentioned, “By showcasing both our scientific leadership and application versatility at Vitafoods Asia in Bangkok, we look forward to co-creating the next wave of innovation in sports nutrition, healthy aging, and everyday vitality.”   According to Mordor Intelligence, the ASEAN Probiotic supplement market size is expected to reach USD198.05 billion by 2030, at a CAGR of 11.43% (2025-2030). “Healthy aging awareness results in rapid growth in ASEAN Probiotic supplement. SynbioTech, supported by 25 years of comprehensive experiences, has been demonstrating its strong global footprint, integrated R&D, manufacturing, and contract manufacturing capabilities (CDMO；Contract Development and Manufacturing Organization). We will actively focus on expanding in Southeast Asia market, especially in Thailand,” GM Sean Yang emphasized. In 2024, TWK10® was officially approved on Thailand’s edible microbial strain list, marking a critical milestone in SynbioTech’s ASEAN strategy and opening new opportunities with local partners. Validated by eight clinical trials, TWK10® has been proven to boost muscle strength, enhance endurance, and improve mobility in older adults.   SynbioTech is empowered to make precision-health products with advanced R&D centers, and high-standard manufacturing facilities. Importantly, the patented SYNTEK® fermentation technology and versatile product formats enable a one-stop CDMO platform offering strain development, clinical validation, custom formulation, and smart packaging solutions. This exclusive high-tech approach supports SynbioTech capturing growth in rapidly expanding international markets.   Looking ahead, SynbioTech, headquarters in Taiwan, commits to advance a broader portfolio of applications and bring probiotics and postbiotics into everyday wellness solutions.</div> NEWS PROVIDED BY SynbioTech Inc.  (<a href="https://www.synbiotech.com/EN/">https://www.synbiotech.com/EN/</a>）  生合生物科技有限公司Thu, 16 Oct 2025 00:00:00 GMTScience That Speaks: SynbioTech Redefines Probiotic Innovation with Five Gold Medals and Grand Special Award in Tokyohttps://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=dc62f27b-947e-4314-b9b5-e04696cab7a9<img alt="" src="/ckfinder/userfiles/Images/%e6%97%a5%e6%9c%ac%e6%9d%b1%e4%ba%ac%e7%99%bc%e6%98%8e%e7%8d%8e2025(1).jpg" style="width: 100%; height: 100%;" /> SynbioTech team with Dr. Yoshio Nakamatsu, Japan’s most prolific inventor, at the 2025 World Genius Convention in Tokyo.   SynbioTech Inc. (TPEX: 1295), a global innovator in probiotic and postbiotic research, proudly announces its remarkable achievements at the 39th World Genius Convention and Education Expo 2025 in Tokyo. Demonstrating excellence in scientific innovation and translational application, SynbioTech was awarded five Gold Medals and the prestigious Grand Special Award, underscoring the company’s leadership in precision nutrition and microbiome science. Among the award-winning entries, LDL557, a postbiotic formulation developed for joint health, received both a Gold Medal and the highest honor of the Grand Special Award. This recognition highlights the product’s groundbreaking approach to modulating inflammation and protecting cartilage through microbiome pathways—establishing a new benchmark in joint health innovation. Another Gold Medal recipient, ABKEFIR®, features a patented symbiotic fermentation process combining seven clinically selected probiotic strains. The formulation supports digestive health by generating beneficial organic acids and polysaccharides, helping inhibit harmful bacteria, promote beneficial flora, and reinforce the gut barrier. In the area of renal health, SynForU®-ReMain was recognized for its ability to reduce gut-derived uremic toxin precursors while preserving gut barrier function. By targeting the gut-kidney axis, this innovation opens new avenues for microbiome-based approaches to managing kidney-related conditions. Two formulations specifically developed for the China market—FS4722 and BY2—also earned Gold Medals. FS4722 demonstrated efficacy in regulating uric acid and reducing inflammation in preclinical models. BY2 showed promise in lipid management through bile salt resistance and cholesterol-binding capacity, addressing the increasing demand for solutions in metabolic health. SynbioTech remains committed to advancing probiotic and postbiotic science across a wide spectrum of health applications—including gut health, immunity, healthy aging, joint mobility, metabolism, and urogenital wellness. These international accolades reaffirm the company’s mission to translate scientific breakthroughs into practical health applications and bring clinically proven innovations to the global market. Reference: <ol> <li value="NaN">Liu, Y., Lou, W., Li, M., Cui, H., Xu, P., & Wu, X. (2023). A strain of Lactiplantibacillus plantarum FS4722 and its application in uric acid reduction, weight management, and anti-inflammation (CN114507621B). China National Intellectual Property Administration.</li> <li value="NaN">Liu, Y., Lou, W., Cui, H., Li, M., Xu, P., & Wu, X. (2023). A cholesterol-lowering Lactobacillus paracasei BY2 and its applications (CN113699063B). China National Intellectual Property Administration.</li> <li value="NaN">SynbioTech Inc. (2022). Fermented composition containing ABKEFIR® multi-strain probiotics and its use in improving gut health (TWI770811B). Taiwan Intellectual Property Office.</li> <li value="NaN">SynbioTech Inc. (2022). Postbiotic composition for joint health based on strain LDL557 and its preparation method (TWI776433B). Taiwan Intellectual Property Office.</li> <li value="NaN">SynbioTech Inc. (2024). Probiotic formulation for renal health regulation via gut-kidney axis, comprising SynForU®-ReMain (TWI854384B). Taiwan Intellectual Property Office.</li> </ol> <o:p></o:p>  生合生物科技有限公司Tue, 08 Jul 2025 00:00:00 GMTTWK10® Secures New U.S. Patent to Support Applications in Healthy Aginghttps://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=fae68f50-7486-43fa-96b3-ce4e68ee7f73<img alt="" src="/ckfinder/userfiles/Images/2025%e7%be%8e%e5%9c%8b%e5%b0%88%e5%88%a9_EN.png" style="width: 100%; height: 100%;" /> Synbio Tech Inc. (TWSE: 1295) proudly announces that its flagship probiotic strain, Lactiplantibacillus plantarum TWK10®, has been granted a new U.S. patent (U.S. Patent No. 12,274,719 B2) titled “Method for Improving Walking Capacity of Elderly Subjects.” This milestone reinforces TWK10®’s scientific potential in nutritional applications targeting the aging population.   According to the patent documentation, the TWK10® strain underwent an 18-week human observation study supported by animal model analysis. The study explored changes in walking performance, repeated sit-to-stand tests, grip strength, and muscle morphology under controlled supplementation. The full dataset is published within the patent to support future scientific reference and development. This newly granted patent marks a strategic expansion of TWK10®’s protection portfolio beyond sports performance into healthy aging. “Securing this U.S. patent further validates our commitment to research-driven innovation across diverse populations,” said general manager, Mr. Chuan-Hsien Yang. “We will continue to align with global regulatory frameworks and collaborate with industry partners to develop science-backed solutions that meet evolving market needs.”   To date, TWK10® has achieved an impressive record: 16 patents granted, 8 human clinical trials, 27 scientific publications, and 13 international awards. Synbio Tech remains committed to its core R&D principles of Safety × Functionality × Stability, driving forward probiotic innovation for active living, healthy aging, and all-stage nutrition worldwide.   Patent Reference: Synbio Tech Inc. (2025). Method for improving walking capacity of elderly subjects (U.S. Patent No. US 12,274,719 B2). United States Patent and Trademark Office. https://patents.google.com/patent/US12274719B2  生合生物科技有限公司Wed, 21 May 2025 00:00:00 GMTSynbio Tech’s TWK10® Wins Vitafoods Europe Innovation Award, Strengthening Global Position in Sports and Healthy Aging Nutritionhttps://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=3cda7253-65d0-42d5-b772-4df503df3140<img alt="" src="/ckfinder/userfiles/Images/1220348-OK(1).png" style="width: 100%; height: 100%;" /> Synbio Tech Vice President Mr. Kuei-Ming Lee leads the team in receiving the award from ESSNA Chair Luca Bucchini. Synbio Tech Inc. (TWSE: 1295) is proud to announce that its proprietary probiotic strain, Lactiplantibacillus plantarum TWK10®, has been named the winner in the “Sports Nutrition and Active Lifestyle Ingredient” category at the 2025 Vitafoods Europe Innovation Awards, one of the nutrition industry’s most prestigious honors. The award recognizes ingredient innovations with high scientific merit, commercial potential, and positive impact on public health. TWK10® was selected for its dual function as both a probiotics and a postbiotics, and for its novel mechanism of action targeting the gut-muscle axis. Originally isolated from traditional Taiwanese fermented cabbages, TWK10® has demonstrated the ability to influence physical performance indicators by modulating gut microbiota and host metabolism. The ingredient has undergone extensive scientific validation, including multiple double-blind, placebo-controlled clinical trials, showing benefits in exercise performance, endurance, and physical recovery. In 2023, TWK10® was further developed into a heat-killed postbiotic format, offering greater formulation stability and compatibility with high-temperature applications such as functional beverages and protein supplements. In addition to its innovation in formulation, TWK10® has recently strengthened its intellectual property portfolio with the issuance of two new invention patents: <ul> <li>U.S. Patent No. 12,274,719 B2 – Method for Improving Walking Capacity of Elderly Subjects (issued April 15, 2025)</li> <li>Korean Patent No. KR 10-2787988 B1 – Recognizing its role in supporting muscle mass and mobility in older adults</li> </ul> These patents reinforce TWK10®’s position as a scientifically supported solution for active aging, opening new market opportunities in mobility support, sarcopenia nutrition, and healthy aging supplementation. “Receiving the Vitafoods Innovation Award is a powerful validation of TWK10®’s clinical strength, safety, and commercial potential,” said Mr. Chuan-Hsien Yang, General Manager of Synbio Tech. “As global demand for evidence-based probiotics and postbiotics continues to grow, we remain committed to expanding the global reach of TWK10® through rigorous science and responsible innovation.” To date, TWK10® is supported by 16 granted patents, 8 human clinical studies, 27 peer-reviewed publications, and 13 international awards, solidifying its role as a leading functional strain in the global probiotic industry. Synbio Tech continues to advance its mission of Changing Lives with Probiotics, driving forward the next generation of microbiome-based solutions for performance, recovery, and healthy aging. Patent References: <ul> <li>U.S. Patent No. 12,274,719 B2. Method for Improving Walking Capacity of Elderly Subjects. Issued April 15, 2025.</li> <li>Korean Patent No. KR 10-2787988 B1. Methods for Treating Sarcopenia and Supporting Muscle Mass. Issued by the Korean Intellectual Property Office.</li> </ul>  生合生物科技有限公司Wed, 21 May 2025 00:00:00 GMTTWK10® Secures Korean Patent, Reinforcing Its Potential in Muscle Health Applicationshttps://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=76fd8754-55fd-48e6-bb2e-2aad94fb80d1<img alt="" src="/ckfinder/userfiles/Images/2025%e9%9f%93%e5%9c%8b%e5%b0%88%e5%88%a9-EN.png" style="width: 100%; height: 100%;" /> Synbio Tech Inc. (1295.TW) proudly announced that its flagship probiotic strain, Lactiplantibacillus plantarum TWK10®, has achieved another patent milestone with the official approval from the Korean Intellectual Property Office (Patent No. KR 10-2787988B1). The patent, titled “Methods of maintaining or increasing muscle mass and strength in elderly subjects”, highlights TWK10®'s unique potential in supporting mobility and vitality, earning further international recognition. TWK10® is a proprietary probiotic strain isolated from traditional Taiwanese fermented cabbage. Supported by scientific research, TWK10® has shown great potential in sports nutrition and healthy aging, contributing to physical performance and helping to maintain overall body function. Its ability to support active lifestyles makes TWK10® a valuable ingredient in functional nutrition. The granting of this Korean patent not only reinforces the scientific credibility of TWK10® as a food ingredient for muscle health applications, but also broadens its possibilities for incorporation into a wide range of food products and dietary supplements. Mr. Chuan-Hsien Yang, General Manager of Synbio Tech Inc., commented: "The core mission behind TWK10®'s development is to provide a safe, clinically supported, and versatile probiotic solution that helps individuals across all ages maintain vitality and support everyday mobility. We are delighted that our continuous efforts have once again been recognized internationally. Moving forward, we will further accelerate TWK10®'s global expansion and application development, creating greater value for healthier living." To date, TWK10® has conducted 7 human clinical trials, received 11 international awards, secured 13 global patents, and published over 27 scientific papers. Furthermore, TWK10® has successfully obtained health claims approval or strain registration in multiple countries, including the United States, Canada, Taiwan, Thailand, Malaysia, and South Korea. These achievements underscore TWK10®'s outstanding safety profile, regulatory compliance, and market potential, providing strong assurance and confidence for global partners and brand customers.  生合生物科技有限公司Thu, 24 Apr 2025 00:00:00 GMTSynbio Tech’s Research Excellence Recognized Globally: TWK10® Study Wins Wiley’s Prestigious 'Top Cited Article' Awardhttps://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=25feefbf-8421-4956-9b10-379b38081086<img alt="" src="/ckfinder/userfiles/Images/TWK10%e6%ad%bb%e8%8f%8c%e4%bf%83%e9%80%b2%e9%81%8b%e5%8b%95%e8%a1%a8%e7%8f%be%e6%96%87%e7%ab%a0_EN(4).jpg" style="width: 100%; height: 100%;" /> TAIWAN, Kaohsiung – March 31, 2025 – Synbio Tech Inc. (TWSE: 1295) has once again demonstrated its scientific expertise in the field of probiotics and postbiotics. The company’s groundbreaking research paper, “Effects of heat-killed Lactiplantibacillus plantarum TWK10 on exercise performance, fatigue, and muscle growth in healthy male adults,” published in the esteemed journal Physiological Reports, has been awarded Wiley’s 2023 Top Cited Article accolade. This recognition underscores TWK10®’s significant impact on the global scientific community and highlights Synbio Tech’s innovation in the functional probiotics and postbiotics sector. Wiley (John Wiley & Sons, Inc.), founded in 1807, is a globally recognized academic publishing leader known for its rigorous standards and extensive academic influence. The “Top Cited Article” award reflects the paper’s substantial impact and reference value within the scientific community. Synbio Tech’s TWK10® research achieving this recognition signifies the groundbreaking nature of its findings, particularly in the domains of sports nutrition and healthy aging. It also marks a milestone for Taiwan’s biotechnology achievements being acknowledged on an international platform. The study systematically examined the effects of Lactiplantibacillus plantarum TWK10® as a postbiotic on exercise performance, fatigue recovery, and muscle growth. Clinical trial results demonstrated that participants consuming TWK10® postbiotics for six consecutive weeks experienced significant improvements in endurance, grip strength, and muscle mass. Additionally, reductions in lactate and ammonia levels were observed during and after exercise, indicating enhanced physical performance and recovery. These findings provide strong scientific evidence supporting TWK10®’s application in sports nutrition. Mr. Yang Chuan-Hsien, General Manager of Synbio Tech, stated, “Receiving Wiley’s Top Cited Article award is a tremendous honor for our research team. It not only validates our efforts in scientific innovation and evidence-based research but also motivates us to further advance the application of TWK10® in the global sports nutrition and healthy aging markets. We remain committed to providing superior health solutions for consumers worldwide.” TWK10®'s dual-functionality as both a probiotic and postbiotic enables its application across various sectors, including sports supplements, healthy aging products, and foods and beverages meeting clean-label and plant-based market demands. With registrations completed in the United States, Canada, South Korea, Thailand, Mexico, Malaysia, Taiwan, and more, TWK10® continues to gain approval from global markets. As demand for scientifically validated probiotics grows, Synbio Tech will continue to drive innovation and contribute to the global health industry with its Taiwanese expertise. Reference “Effects of heat-killed Lactiplantibacillus plantarum TWK10 on exercise performance, fatigue, and muscle growth in healthy male adults” Published in: Physiological Reports, 2023 DOI: 10.14814/phy2.15835  生合生物科技有限公司Fri, 28 Mar 2025 00:00:00 GMTSynbio Tech Inc. TWK10® Achieves Dual Recognition at Malaysia MTE International Invention Award and Taiwan National Innovation Awardhttps://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=ec4d2f06-315e-4501-a03f-b9792485cd84<img alt="" src="/ckfinder/userfiles/Images/DSC04956(1).jpg" style="width: 100%; height: 100%;" /> <div style="text-align: justify;">From left to right: Mr. Lian-Chwan Yang, President of Synbio Tech Inc., and Mr. San-Land Young, CEO of Synbio Tech Inc., receiving the 21st Taiwan National Innovation Award for TWK10®. Synbio Tech Inc. (1295:Taipei) proudly announces that its flagship probiotic strain, TWK10® (Lactiplantibacillus plantarum TWK10), has received two prestigious honors: the Gold Medal at the 2025 Malaysia Technology Expo (MTE) and the 21st Taiwan National Innovation Award. These dual recognitions underscore Synbio Tech's commitment to scientific excellence and reinforce its position as a pioneer in the field of healthy aging. Global Recognition for Innovation in Healthy Aging At the 24th Malaysia Technology Expo (MTE) 2025, TWK10® stood out among 425 innovative technologies and products from more than 15 countries, including the United States, the United Kingdom, Japan, Singapore, Indonesia, and Egypt. The MTE is one of Asia's most influential platforms for technological innovation. TWK10®'s groundbreaking application in healthy aging earned it the coveted Gold Medal, affirming its scientific excellence and global relevance. Scientific studies have demonstrated that TWK10® significantly improves age-related muscle weakness, bone loss, and cognitive decline. By modulating the gut microbiome, TWK10® promotes healthy aging, positioning it as a leading innovation in the global fight against age-associated health challenges. These findings have been published in top-tier international journals, gaining widespread academic recognition. “TWK10® represents a breakthrough in probiotic science, providing innovative solutions for healthy aging through gut microbiome modulation,” said Mr. San-Land Yang, Chief Executive Officer of Synbio Tech Inc. “This international recognition is a testament to our dedication to scientific innovation and global health advancement.” National Innovation Award: A Testament to Market Potential and Technological LeadershipIn addition to its international acclaim, TWK10® has also been honored with the 21st Taiwan National Innovation Award—one of the country's highest accolades in biotechnology. This award recognizes products and enterprises demonstrating excellence in technological innovation, application, and market potential. TWK10® has successfully redefined the boundaries of traditional probiotic applications. Backed by rigorous scientific research and outstanding global market performance, it has strengthened Taiwan's standing in the global probiotic industry. This achievement not only highlights Synbio Tech's commitment to scientific rigor but also underscores Taiwan’s growing influence in the biotechnology sector. “Receiving these two prestigious awards is more than an honor—it is a validation of Synbio Tech's unwavering commitment to research excellence and global health innovation,” Mr. Yang added. “We will continue to advance clinical research, expand global partnerships, and explore new market opportunities to elevate Taiwan's biotech industry on the international stage.” Driving Global Health Innovation We are dedicated to advancing the science of probiotics and postbiotics. The dual recognition of TWK10® underscores the company's leadership in innovative R&D and highlights its strong position in the competitive global market. Looking forward, Synbio Tech will continue to uphold its mission of “Changing Lives with Probiotics,” focusing on scientific advancement, expanding innovative applications, and contributing to the development of the global health industry. References</div> <ul> <li style="text-align: justify;">Lee, C. C., Liao, Y. C., Lee, M. C., Lin, K. J., Hsu, H. Y., Chiou, S. Y., ... & Watanabe, K. (2021). Lactobacillus plantarum TWK10 attenuates aging-associated muscle weakness, bone loss, and cognitive impairment by modulating the gut microbiome in mice. Frontiers in Nutrition, 8, 708096.</li> <li style="text-align: justify;">Lee, M. C., Tu, Y. T., Lee, C. C., Tsai, S. C., Hsu, H. Y., Tsai, T. Y., ... & Huang, C. C. (2021). Lactobacillus plantarum TWK10 improves muscle mass and functional performance in frail older adults: A randomized, double-blind clinical trial. Microorganisms, 9(7), 1466.</li> <li style="text-align: justify;">Synbio Tech Inc. (2023). Lactobacillus plantarum TWK10 composition for improving aging-related conditions (Japanese Patent No. JP7410569B2).</li> <li style="text-align: justify;">Synbio Tech Inc. (2022). Lactobacillus plantarum TWK10 composition for improving aging-related conditions (U.S. Patent Application No. US20220072070A1).</li> </ul> <div style="text-align: justify;"> </div> 生合生物科技有限公司Thu, 13 Mar 2025 00:00:00 GMTSynbio Tech Inc. Approved for OTC Market Listing, Marking a New Milestonehttps://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=dbd196fe-b470-4f9b-8da4-780a583ea0fa<div style="text-align: justify;">We are proud to announce that Synbio Tech Inc. (1295) has officially received approval for our OTC market listing from the Taipei Exchange (TPEx) on December 10th. This milestone reflects years of dedicated efforts under the strategic leadership of our chairman - Mr. Lian-Chuan Yang and the collective commitment of our entire team. Since our founding in 2000, Synbio Tech Inc. has been a pioneer in the probiotics industry, specializing in the research, development, and manufacturing of probiotics. Our products span a wide range of applications, including human health, animal wellness, plant care, and aquaculture. In addition to delivering high-quality probiotic raw materials, we provide CDMO, OEM, and ODM services to meet the unique needs of our partners. “Our OTC market listing is not just a financial milestone, but a testament to our unwavering commitment to leveraging microbiome science for global health and sustainability,” said Mr. Yang. “This achievement will enable us to accelerate our strategic growth, expand our reach, and further our mission ─ Changing Lives with Probiotics.” Synbio Tech’s financial performance underscores its strategic vision. In 2023, we achieved revenues of NT$823 million, with a net profit of NT$ 113 million and earnings per share (EPS) of NT$3.67. The first three quarters of 2024 have been even more remarkable, with revenues reaching NT$743 million, net profit of NT$148 million, and EPS of NT$4.71—significant improvements that validate our strategic approach. Looking ahead, we remain focused on advancing microbiome research and expanding the potential of probiotics in human health, agricultural applications, and environmental sustainability. By working closely with our partners, we aim to make a meaningful impact—improving global well-being while contributing to a healthier planet. “As we take this next step forward, we look forward to collaborating with our stakeholders, partners, and the wider community to shape a healthier, more sustainable future—together,” said Mr. Yang.  </div> 生合生物科技有限公司Wed, 25 Dec 2024 00:00:00 GMTTaiwanese Probiotic Strain Lactiplantibacillus plantarum TWK10® Achieves Major Milestones in Thailand and the United Stateshttps://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=89491e08-3308-483c-98d5-3a85ef862b0b<img alt="Taiwanese Probiotic Strain Lactiplantibacillus plantarum TWK10® Achieves Major Milestones in Thailand and the United States" src="/ckfinder/userfiles/Images/241014-TWK10%e5%8f%96%e5%be%97%e6%b3%b0%e5%9c%8b%e5%8f%af%e4%be%9b%e9%a3%9f%e7%94%a8%e7%9b%8a%e7%94%9f%e8%8f%8c%e5%90%8d%e5%96%ae-EN_%e5%b7%a5%e4%bd%9c%e5%8d%80%e5%9f%9f%201.jpg" style="width: 100%;" /> <div style="text-align: justify;"> The Taiwanese probiotic strain Lactiplantibacillus plantarum (formerly known as Lactobacillus plantarum) TWK10® has recently achieved two significant breakthroughs in the international market, further solidifying its leading position in the global sports nutrition and healthy aging sectors.   TWK10® has successfully completed its registration in Thailand. This significant achievement marks TWK10's official inclusion in the country's List of Probiotic Microorganisms in Foods, paving the way for its broader application and availability in the Thai market. Adding to this momentum, TWK10® has also received Self-affirmed GRAS (Generally Recognized As Safe) status in the United States, further establishing its safety and efficacy for consumers.   TWK10® stands out for its versatility, functioning effectively on muscle health both as a probiotic and a postbiotic. This dual capability allows it to cater to a diverse range of supplements and food applications, enhancing its value in the wellness market. Moreover, TWK10® is celebrated as the first probiotic product in Taiwan to receive the "anti-fatigue" health claim. This prestigious recognition underscores its unique benefits and sets a new standard for probiotic innovations in the region.   TWK10® offers several key health benefits, including enhancing exercise performance by increasing muscle mass and recovery and reducing fatigue, making it an ideal supplement for athletes and fitness enthusiasts. Additionally, TWK10® improves muscle quality and promotes muscle endurance, contributing to better mobility and quality of life for elderly groups.   General Manager Yang Chuan-Hsien stated, "The successful registration of TWK10® in Thailand and its Self-affirmed GRAS status are significant milestones that reflect our commitment to advancing probiotic science. TWK10®'s proven benefits on muscle health position it as a leader in the sports nutrition and healthy aging markets, driving innovation and improving lives."   For more information about TWK10® and our range of probiotic solutions, please vist www.synbiotech.com   About Synbio Tech Synbio Tech is dedicated to pioneering probiotic and postbiotic solutions. Our mission is to change lives with probiotics through innovative products backed by rigorous scientific research.   TWK10® is registered trademark by Synbio Tech Inc.</div> <img alt="Taiwanese Probiotic Strain Lactiplantibacillus plantarum TWK10® Achieves Major Milestones in Thailand and the United States" src="/ckfinder/userfiles/Images/241014-TWK10%20%e5%be%8c%e7%94%9f%e5%85%83(Heat-killed)%e5%ae%8c%e6%88%90%e7%be%8e%e5%9c%8bSelf-affirmed%20GRAS%e8%aa%8d%e8%ad%89-EN_%e5%b7%a5%e4%bd%9c%e5%8d%80%e5%9f%9f%201.jpg" style="width: 100%;" />  生合生物科技有限公司Wed, 16 Oct 2024 00:00:00 GMTSynbio Tech's SynForU™-GastroKeep Secures Chinese Patent, Advancing Probiotic Innovation for Stomach Healthhttps://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=86a4b658-8024-4e77-bc83-b75faaf2ef68<img alt="" src="/ckfinder/userfiles/Images/SynForU-GastroKeep%e6%a6%ae%e7%8d%b2%e4%b8%ad%e5%9c%8b%e7%99%bc%e6%98%8e%e5%b0%88%e5%88%a9-EN.JPG" style="width: 800px; height: 450px;" /> Synbio Tech, a leader in probiotic research and development, has achieved a significant milestone with its innovative product, SynForU™-GastroKeep. The company's Lactobacillus plantarum LP23 strain, a crucial component of this functional probiotic, has been granted a Chinese invention patent (Patent No.: ZL 2023 1 0119349.6) for its stomach health benefits.   This breakthrough is the result of collaborative efforts between Synbio Tech's strain research institute and the R&D team in Yangzhou. SynForU™-GastroKeep combines several patented probiotics designed to withstand stomach acid and bile salts, effectively colonize the human stomach, and promote overall digestive health.   In response to the growing global concern of chronic stomach discomfort, often linked to Helicobacter pylori, Synbio Tech has developed SynForU™-GastroKeep as a natural and effective solution. Scientific research suggests that probiotics can inhibit H. pylori growth, balance gut microbiota, and alleviate digestive issues.   Xu Tian-Ken, General Manager of Synbio Tech Yangzhou, emphasized the importance of this patent for the Chinese market. "This recognition not only validates our R&D team's expertise but also strengthens our position as innovators in probiotic technology. It will significantly boost SynForU™-GastroKeep's market presence in China and enhance our brand's competitiveness."   With over two decades of experience in probiotic research, Synbio Tech remains committed to its mission of "changing lives with probiotics." The company plans to increase its investment in the Chinese market, focusing on continuous innovation to meet the growing demand for high-quality stomach health products.   This patent marks another step in Synbio Tech's journey to expand globally while maintaining a strong presence in Taiwan, as it continues to develop superior products that contribute to richer, healthier lives for consumers worldwide. Reference: <ol> <li> <h1>1.Shirani, M., Pakzad, R., Haddadi, M. H., Akrami, S., Asadi, A., Kazemian, H., Moradi, M., Kaviar, V. H., Zomorodi, A. R., Khoshnood, S., Shafieian, M., Tavasolian, R., Heidary, M., & Saki, M. (2023). The global prevalence of gastric cancer in Helicobacter pylori-infected individuals: a systematic review and meta-analysis. BMC infectious diseases, 23(1), 543.</h1> </li> <li> <h1>2.Zheng, P. X., Fang, H. Y., Yang, H. B., Tien, N. Y., Wang, M. C., & Wu, J. J. (2016). Lactobacillus pentosus strain LPS16 produces lactic acid, inhibiting multidrug-resistant Helicobacter pylori. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 49(2), 168–174.</h1> </li> <li value="3">Google Patents. (2023). Lactobacillus plantarum for preventing and assisting in treating stomach deficiency-cold and application thereof. Patent ZL 2023 1 0119349.6. Retrieved from <a href="https://patents.google.com/patent/CN116004475A/zh" target="_new">https://patents.google.com/patent/CN116004475A/zh</a>.</li> </ol>    生合生物科技有限公司Thu, 11 Jul 2024 00:00:00 GMTSynbio Tech and Korea's Cosmax NBT Sign Research Collaboration Agreement to Deepen Cooperationhttps://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=c5f4dda8-6d11-4203-b723-32dffd0d0f69<div style="text-align: justify;">Synbiotech (1295:TT) and Cosmax NBT Inc., a leading global Korean functional foods manufacturer, have entered into a strategic research and development collaboration to explore the potential of Lactiplantibacillus plantarum (TWK10) in addressing metabolic syndrome. According to the latest study published in the Journal of Functional Foods, TWK10 has demonstrated significant potential in reducing weight gain and adipose tissue mass, improving glucose and lipid profiles, regulating the adiponectin-leptin ratio, protecting liver function, and optimizing energy metabolism. These findings underscore the promise of TWK10 in combating metabolic syndrome.   TWK10 is a probiotic strain derived from Taiwanese fermented cabbage and has secured numerous health certifications in Canada, Taiwan, and South Korea. With 10 global patents and 17 scientific publications, TWK10 is an innovative probiotic backed by over a decade of research. Synbiotech's CEO, Dr. San-Land Yang, said, "TWK10 results from ten years of research, culminating in five clinical trials that solidified it as the world's first probiotic to enhance athletic performance and muscle quality. This collaboration not only encompasses commercial aspects but also includes clinical trials and marketing strategies, setting a new milestone in the probiotic health industry."   Wonil Yun, CEO of Cosmax NBT, remarked, "Cosmax NBT is focused on developing high-quality functional ingredients and ensuring each product meets the highest standards. We eagerly anticipate collaborating closely with Synbiotech to maximize TWK10's functional benefits. TWK10 is the first probiotic in South Korea with athletic performance benefits, with several products already launched in the South Korean market. Moving forward, the two companies will strengthen their partnership to conduct in-depth research on TWK10's potential in metabolic syndrome, combining our market insights and R&D strengths to expand product applications and drive greater success in the Korean market."   According to the Korea Health Functional Food Association, the health food market has been expanding since 2014, with a projected 2023 market size of KRW 6.2 trillion, representing a 27% increase over five years. Probiotics have emerged as the third largest category of functional health foods after red ginseng, vitamins and minerals. Their rapid growth is attributed to rising health awareness, the pandemic, and product innovation. Manufacturers are diversifying their product offerings and expanding sales through online platforms, while strict government certification and scientific research support bolster consumer confidence.   This R&D collaboration leverages both parties' robust scientific research and shared business philosophies to propel TWK10 into a groundbreaking functional product that can transform human health. Looking ahead, both Synbiotech and Cosmax NBT aspire to unlock future possibilities together, jointly developing the next generation of probiotics and maintaining their leadership in the probiotics market.</div>   <img alt="Synbio Tech collaborates with Korean health food giant Cosmax NBT to sign a research cooperation agreement." src="/ckfinder/userfiles/Images/DSC04708-.png" style="width: 100%;" /> <div style="text-align: justify;">Synbio Tech collaborates with Korean health food giant Cosmax NBT to sign a research cooperation agreement. Reference</div> <ol> <li style="text-align: justify;">Zheng, Y., Lee, Y., Kweon, M., Kim, S., & Kang, I. J. (2024). Evaluate and compare the anti-obesity effects of two probiotic preparations in high-fat diet-induced obese mice. Journal of Functional Foods, 116, 106199. https://doi.org/10.1016/j.jff.2024.106199</li> <li style="text-align: justify;">Korean Health Functional Food Association. (2023, December 7.). Market trends and growth of health functional foods. Retrieved from https://www.khff.or.kr/user/info/InfoBoardUserView.do?_menuNo=369&boardSeqno=10035&postsSeqno=118067</li> <li style="text-align: justify;">Shah, P. (2024, March 18). South Korea’s functional probiotics market growing faster than generic probiotics. NutraIngredients-Asia. https://www.nutraingredients-asia.com/Article/2024/03/18/South-Korea-s-functional-probiotics-market-growing-faster-than-generic-probiotics</li> </ol>  生合生物科技有限公司Tue, 21 May 2024 00:00:00 GMTSynbio Tech Shines at the 38th World Genius Convention and Education Expo in Japan, Clinching a Gold Medalhttps://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=3100f520-d5b2-4dde-b757-cd6ecbe2e76d<img alt="Synbio Tech Shines at the 38th World Genius Convention and Education Expo in Japan, Clinching a Gold Medal" src="/ckfinder/userfiles/Images/2024%e7%99%bc%e6%98%8e%e7%8d%8ebanner_EN.jpg" style="width: 100%;" /> <div style="text-align: justify;"> Synbio Tech has been awarded a prestigious gold medal at the "38th World Genius Convention and Education Expo 2024," held May 9-10 at the Tokyo International Forum. This globally significant event in the invention community attracted participants from over ten countries, including the United States, Canada, Thailand, Korea, China, Taiwan, and host nation Japan, showcasing over a hundred innovative entries.   Synbio Tech distinguished itself with its probiotic product, Lactiplantibacillus plantarum TWK10®, designed to enhance muscle mass and endurance in the elderly. The company's long-term commitment to research and development in probiotics is reflected in its diverse business model, which spans product design to manufacturing, all backed by advanced scientific validation and clinical trials. This comprehensive approach ensures that consumers benefit from high-performance products trusted worldwide.   General Manager Yang Chuan-Hsien highlighted the company's use of microbiome genomics and its unique SYNTEK® thorough technology, which optimizes every step from strain selection to freeze-drying processes, thereby enhancing the functional attributes of TWK10®. Clinical trials of TWK10® have demonstrated improvements in muscle mass, endurance, grip strength, mobility, and dynamic balance in older adults, reducing risks associated with sarcopenia and frailty, and significantly enhancing the quality of life for this population.   With the global aging population expanding, particularly in developed countries, sarcopenia is becoming an increasingly prevalent health concern. According to the World Health Organization, the global population aged 65 and above is projected to grow from 700 million to 2 billion by 2050. TWK10® not only meets this rapidly increasing market demand but also offers a scientifically-based solution to address significant health challenges faced by the elderly worldwide. As the aging demographic grows, so does the market for senior health products, highlighting the increasing demand for health-related consumption among older adults. Synbio Tech's innovative probiotic product is expected to see broad application and promotion on the international stage.</div>  生合生物科技有限公司Mon, 13 May 2024 00:00:00 GMTAB-Kefir Probiotic from Synbio Tech Secures U.S. Patent, Paving the Way for Global Health and Dietary Innovationhttps://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=79ef6ac7-a35f-46ee-b194-5bda06971d09<img alt="AB-Kefir Probiotic from Synbio Tech Secures U.S. Patent, Paving the Way for Global Health and Dietary Innovation" src="/ckfinder/userfiles/Images/%e7%94%9f%e5%90%88%e7%94%9f%e7%89%a9%e7%a7%91%e6%8a%80AB-Kefir%e7%9b%8a%e7%94%9f%e8%8f%8c%e7%8d%b2%e7%be%8e%e5%b0%88%e5%88%a9%e5%9c%96_%e8%8b%b1%e6%96%87.png" style="width: 100%;" /> <div style="text-align: justify;"> Synbio Tech's flagship product, "AB-Kefir Probiotics," was recently granted a U.S. invention patent (Patent Number: US 11,839,635B1). This award not only affirms the company’s outstanding achievements in probiotic research and innovation but also underscores AB-Kefir's leadership in the global health and dietary market. The acquisition of this patent demonstrates the unique efficacy of AB-Kefir in combating foodborne pathogens such as Salmonella, providing consumers with a safer and more effective solution for gut health. Kefir, originating from the Caucasus region, is a traditional fermented beverage known for its rich probiotic and prebiotic components. It has become part of the modern healthy dietary culture passed down through generations. Synbio Tech has created the globally unique AB-Kefir Probiotic using cutting-edge research and production technologies. The innovative SYNTEK® thorough symbiotic fermentation production module brings a revolutionary quality breakthrough. Selecting five probiotic strains (Lactobacillus rhamnosus LRH10, Lactobacillus paracasei LPC12, Lactobacillus fermentum LF26, Streptococcus thermophilus ST30, Lactobacillus helveticus LH43) for a unique symbiotic fermentation process, and especially adding Lactobacillus acidophilus LA1063 and Bifidobacterium longum BL986 to meet contemporary dietary needs, AB-Kefir is tailored to provide a stable, higher CFU probiotic product. AB-Kefir preserves the traditional health benefits of kefir and demonstrates outstanding effects through scientific experiments in digestion absorption, promoting bowel movements, maintaining bacterial ecosystem balance, and resisting pathogens. As the role of probiotics in contemporary healthy living becomes increasingly crucial, the success of AB-Kefir marks not only a significant achievement in technological innovation but also symbolizes the perfect integration of tradition and modern science, heralding a healthier and brighter future. Synbio Tech will continue its commitment to developing more high-quality health products, aiming to provide comprehensive health support to consumers worldwide. This breakthrough solidifies Synbio Tech's global health and dietary leadership and offers more choices for healthy consumers.</div>  生合生物科技有限公司Wed, 28 Feb 2024 00:00:00 GMTSynbio Tech's TWK10®: A New Era in Elderly Muscle Health with Japanese Patent Milestonehttps://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=2806893e-e604-4aca-9c6b-f4a0e5da7a1e<img alt="Synbio Tech's TWK10®: A New Era in Elderly Muscle Health with Japanese Patent Milestone" src="/ckfinder/userfiles/Images/240226-%e7%94%a2%e6%a5%ad%e8%b3%87%e8%a8%8a-TWK10%e5%8f%96%e5%be%97%e6%97%a5%e6%9c%ac%e5%b0%88%e5%88%a9-EN_%e5%b7%a5%e4%bd%9c%e5%8d%80%e5%9f%9f%201.png" style="width: 100%;" /> <div style="text-align: justify;"> Synbio Tech Inc. (1295:TT) recently announced that its probiotic product aimed at improving muscle mass and endurance in the elderly, Lactobacillus plantarum TWK10®, has obtained a Japanese invention patent (Patent No.: JP7410569). This milestone not only symbolizes the commitment to scientific innovation but also strengthens Synbio Tech's leadership in the global health industry.   With the rapid growth of aging societies in Japan and globally, the health and quality of life of the elderly have become significant issues. Japan, being a highly aged country, urgently requires innovative products that can enhance the quality of life for the elderly. TWK10® emerged in this context, improving muscle mass and endurance through the gut-muscle axis, thereby enhancing the mobility and dynamic balance of the elderly, further improving their quality of life.   The research and development of TWK10® are based on a solid scientific foundation, with several clinical trials completed and published in international journals, proving its effectiveness in improving muscle health. The acquisition of the Japanese invention patent not only represents international recognition of TWK10®'s scientific innovation but also symbolizes the potential of the product to improve the quality of life for the elderly and its prospects for expansion in the global aging market.   Synbio Tech is dedicated to promoting TWK10®, a muscle probiotic derived from unique Taiwanese pickles, proven by scientific research to significantly improve muscle mass. By applying this unique probiotic to health products, the company aims to bring a healthier, more vibrant lifestyle to the elderly population worldwide.</div>  生合生物科技有限公司Mon, 26 Feb 2024 00:00:00 GMTSynbio Tech's Innovative Probiotic Approach Revitalizes Gut and Vaginal Microbiota in Pregnant Women with Candidiasishttps://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=93f60095-2529-4fe5-af5d-a7980ba0cc05<img alt="Synbio Tech's Innovative Probiotic Approach Revitalizes Gut and Vaginal Microbiota in Pregnant Women with Candidiasis" src="/ckfinder/userfiles/Images/240207-SynForU-HerCare%e6%96%b0%e8%81%9e%e7%94%a8%e5%9c%96%e7%89%87-EN.jpg" style="width: 100%;" /> Innovative research and proprietary technologies have placed Synbio Tech, Inc. (1295:TT) at the forefront of the probiotics field. The company's advancements not only enhance probiotic production efficiency but also significantly benefit intestinal health, aligning with the rising global demand for probiotics. Synbio Tech's ongoing innovations, underscored by its plan to build a new manufacturing facility in Kaohsiung Science Park, reaffirm its growing influence in the expanding global probiotic market. According to Mordor Intelligence, this market is expected to grow from US$73.377 billion in 2023 to US$105.49 billion by 2028, highlighting the increasing relevance of probiotics in health and nutrition. Recently, the spotlight has been on the potential of probiotics in women's health, a sector ripe for market growth. Synbio Tech is poised to be a key player in this arena, especially with its groundbreaking probiotic product SynForU™-HerCare for vaginal candidiasis. This latest research marks a significant stride in maternal healthcare, offering promising benefits for the health and well-being of pregnant women."   Synbio Tech's recent study reveals that their SynForU-HerCare probiotic effectively reduces vaginal candidiasis in pregnant women. This common condition during pregnancy can impact both mother and baby's health. The study shows that SynForU-HerCare, by suppressing harmful bacteria like Prevotella and Atopobium and boosting beneficial Lactobacillus, helps maintain a healthy balance of intestinal and vaginal flora. This probiotic also supports diverse gut bacteria and Firmicutes, crucial for nutrient absorption, protection, and immune function. These findings offer a non-invasive way to enhance microbiome health during pregnancy, marking a significant advancement in women's health. Synbio Tech's innovation in this area underscores their commitment to advanced probiotic applications and women's health programs."   Moreover, Synbio Tech's continued investment in the research and development of new products serves to emphasize its ongoing commitment to innovation in the field of women's health. On the basis of its scientific research, the company is committed to addressing the health-related challenges that women face at different stages of life, and looks forward to introducing further innovative health solutions in the future. These efforts not only demonstrate the company's expertise in women's healthcare but also its long-term commitment to improving women's health worldwide.   Reference: Lactobacillus probiotics restore vaginal and gut microbiota of pregnant women with vaginal candidiasis Probiotics Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)  生合生物科技有限公司Wed, 07 Feb 2024 00:00:00 GMTSynbio Tech's Probiotic Lactiplantibacillus plantarum TWK10 Receives Health Claim for Anti-fatigue in Taiwanhttps://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=e6c2b2bd-9db9-4c13-bb1c-52d9b03ff4d6<div style="text-align: justify;"><img alt="Receives Health Claim for Anti-fatigue in Taiwan" src="/ckfinder/userfiles/Images/240207-TWK10%e5%b0%8f%e7%b6%a0%e4%ba%ba%e6%96%b0%e8%81%9e%e7%94%a8%e5%9c%96%e7%89%87-EN(1).jpg" style="width: 100%;" /> Synbio Tech is thrilled to announce that its groundbreaking probiotic strain, Lactiplantibacillus plantarum TWK10, has been awarded a prestigious health claim by the Taiwan Food and Drug Administration (FDA) for its anti-fatigue properties. This represents a significant milestone in recognizing TWK10's health benefits, especially its ability to delay the onset of exercise-induced fatigue and enhance post-exercise recovery. The 'little green man' certification mark from the Taiwan FDA stands as a solid endorsement of the strain's scientifically supported benefits, boosting its credibility and consumer trust.   Lactiplantibacillus plantarum TWK10, formerly known as Lactobacillus plantarum, has undergone rigorous testing and research, culminating in this landmark approval. Studies published in reputable journals such as the Physiological Reports and MDPI Microorganisms have highlighted the strain's remarkable functionality. Notably, research findings have demonstrated TWK10's effectiveness in improving physical endurance and accelerating fatigue recovery, making it a groundbreaking solution for athletes and active individuals seeking natural ways to enhance their performance and well-being.   A standout feature of Lactiplantibacillus plantarum TWK10 is its adaptability for use in both live probiotic and heat-killed postbiotic forms. This adaptability broadens its application across an array of dietary supplements and functional foods, meeting a variety of consumer demands and preferences.   The anti-fatigue health claim for Lactobacillus plantarum TWK10 is a significant milestone for Synbio Tech and the broader field of probiotic research. It paves the way for new product developments that can contribute to the health and performance of individuals globally. Synbio Tech is dedicated to continuing its research and innovation in probiotics, to deliver products that can make a real difference in people's lives.   About Synbio Tech: Synbio Tech is a global leader in the field of biotechnology, specializing in the research, development, and commercialization of high-quality probiotics. With a foundation built on innovation and scientific excellence, Synbio Tech is committed to enhancing human health, animal health and well-being through natural, scientifically proven solutions.  </div> 生合生物科技有限公司Wed, 07 Feb 2024 00:00:00 GMTSplendid Achievements in 2023, Embracing New Challenges in 2024https://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=2a146888-047d-4a96-90c3-70989e042456<img alt="" src="/ckfinder/userfiles/Images/%E7%B2%BE%E5%BD%A9%E5%8D%93%E8%B6%8A2023%20%E9%82%81%E5%90%912024%E6%96%B0%E6%8C%91%E6%88%B0.png" style="width: 100%;" /> <div style="text-align: justify;"> The year 2023 marked a journey filled with accomplishments and challenges for Synbio Tech. A particularly noteworthy achievement is the official listing on the stock exchange at the end of the year, symbolizing not just recognition for our long-standing commitment to probiotic research and manufacturing but also the collaborative effort and trust of our customers, suppliers, and colleagues. This milestone signifies a pivotal step towards establishing Synbio Tech as a leading international corporation.   Throughout the past year, we made substantial progress in critical areas, achieving breakthroughs in the domestic market and actively expanding our global footprint. This underscores our exceptional capabilities and achievements within the probiotics field. Our active participation in numerous international conferences and trade shows further solidified relationships with partners and customers worldwide, elevating the global recognition of Synbio Tech. These experiences and accomplishments provide a robust foundation for our continued growth and progression.   Review of 2023 Exhibitions In the previous year, our research findings were published in prestigious international journals, and our products were successfully obtained patented for international invention. These achievements have highlighted the excellence and innovation of products such as the TWK10® and SynForU® series. This not only underscores our leadership in probiotic research but also serves as evidence of our international recognition and influence. Synbio Tech remains committed to innovation and scientific research, ensuring a continued impact on the global probiotics industry. Our plans include sustained investment in research and innovation to drive continuous improvement and optimization of our products, maintaining our position at the forefront of the industry.   In 2023, Synbio Tech achieved notable milestones, reflecting the efforts of the past year and laying a solid foundation for future development. Here is an overview of our key accomplishments: 1.Successful Stock Exchange Listing: Establishing a robust foundation for long-term development under the new name, Synbio Tech. 2.TWK10 Patents Granted In the US and Korea: Demonstrated a leading position and global recognition in probiotic research and development. 3.International Publication of Synforu-Hercare in Journals: Highlighting in-depth research and contributions to science. 4.Introduction of Innovative Postbiotic Products: Consolidating our position as industry innovators. 5.Completion of Trademark Coverage In 90% of the Global Market: Strengthened international brand influence. 6.Participation in Over 20 International Trade Shows and Conferences: Expanded the global network of partners. 7.Diamond Sponsor for Growth Asia 2023: Enhanced brand visibility in Asia. 8.Introduction of New Machinery in Japan to Deepen Technological Automation: Initiated the transformation into an intelligent enterprise, enhancing manufacturing quality and efficiency to meet market demands. 9.Strengthening Global Product Lines: Met diverse customer needs in different regions. Synbio Tech also emphasizes contributions to society. In 2023, our collaboration with the Luchu Social Welfare Association made significant progress in community initiatives, providing emergency assistance, addressing welfare gaps, and supporting vulnerable groups. Together, we assisted 551 households, benefiting 1,308 individuals, which reflects our commitment and practice of social responsibility.   As Synbio Tech embraces the opportunities of 2024, the company looks forward to engaging in more scientific research and clinical trials, and deepening its international expansion. With renewed determination and commitment, Synbio Tech aims to provide customers with higher-quality products and services, contributing to the health of humans and animals. We eagerly anticipate achieving more milestones in the global probiotics market in the coming year.   Thank you to each partner for your trust and support over the past year. Looking ahead to 2024, Synbio Tech is set to launch more exciting activities and product plans. We invite you to collaborate with us in facing the new challenges of 2024 and co-creating an even more splendid future for probiotics.</div>   <hr /> <img alt="" src="/ckfinder/userfiles/Images/20240124-2024%E8%B3%80%E5%8D%A1_%E5%B7%A5%E4%BD%9C%E5%8D%80%E5%9F%9F%201%20%E8%A4%87%E6%9C%AC.jpg" style="width: 100%;" />  生合生物科技有限公司Mon, 05 Feb 2024 00:00:00 GMTKidney Care Probiotics, SynForU™ Remain Received The 19th National Innovation Awardhttps://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=ce79e11f-0216-4aa2-82b8-758629439752<img alt="Kidney Care Probiotics, SynForU™ Remain Received The 19th National Innovation Award" src="/ckfinder/userfiles/Images/58401754_s.jpg" style="width: 100%;" /> <div style="text-align: justify;"> The kidneys play a crucial role in maintaining our overall health and well-being. Their primary function is to filter toxins from the blood and convert waste into urine. As we age, kidney function naturally declines, and chronic kidney disease (CKD) can develop, resulting in incomplete or insufficient removal of waste products. CKD is a progressive condition that affects more than 10% of the global population, totaling over 800 million individuals(2). In the realm of kidney health, SynForU™ Remain, lactobacilli probiotic formulation, has demonstrated its efficacy and earned well-deserved recognition through an innovation award. Its positive impact on kidney health has been observed, further emphasizing its potential as a valuable asset in promoting well-being.   Gut microbiota vs kidney disease The gut microbiome and kidney disease are closely interlinked. The gut-kidney axis refers to the bidirectional interaction between intestinal and renal functions. Kidney diseases can disrupt the structure of the gut microbiota, leading to dysbiosis. This dysbiosis, coupled with gastrointestinal disorders, can cause the translocation of microbial compounds with proinflammatory and nephrotoxic properties(4). Gut dysbiosis plays a significant role in the progression of chronic kidney disease (CKD), therefore, microbiota-based strategies could be considered as innovative therapeutic and preventative approaches (1).   Probiotic solution for kidney health SynForU™ Remain, a composition of lactobacilli probiotics including Lactobacillus paracasei LP1411 (MFM 18) and Lactobacillus plantarum LP1410 (MFM 30-3), has emerged as a potential solution for kidney care. In a study conducted by Huang and colleagues using a CKD mouse model, SynForU™ Remain demonstrated significant improvements in kidney function. It reduced kidney injury and fibrotic-related proteins, alleviated oxidative stress and proinflammatory reactions, and enhanced immune responses within the kidneys. Notably, SynForU™ Remain reversed gut dysbiosis, restoring the abundance of beneficial bacteria, especially SCFA producers. This restoration improved the integrity of the intestinal barrier by modulating microbial composition and metabolite production. These findings suggest that SynForU™ Remain could be an effective preventive approach against CKD (1).   Innovating the future of probiotics As a recognition of its innovation and potential impact on kidney care, SynForU™ Remain has been awarded with the 19th National Innovation Award. The award acknowledges the role of innovative probiotic solutions in addressing the challenges posed by CKD and further reinforces the need for microbiota-based therapeutic and preventative strategies. The continued development and application of SynForU™ Remain and probiotic solutions pave the way for a brighter future in kidney health, offering hope for millions of individuals worldwide.</div>   Reference:  1.Huang, et al. (2021). Journal of Agricultural and Food Chemistry, 69(26), 7353-7366. 2.Kovesdy, C. P. (2022). Epidemiology of chronic kidney disease: an update 2022. Kidney International Supplements, 12(1), 7-11. 3.Mijwil, et al. (2021). Applying Machine Learning Techniques to Predict Chronic Kidney Disease in Humans. 4.Stavropoulou, E., et. al. (2021). Front. Med. 7:620102.  生合生物科技有限公司Thu, 29 Jun 2023 00:00:00 GMTSYNBIO TECH INC. receives patent in The United States for Lactobacillus plantarum TWK10® probiotic strainhttps://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=ca015f34-5a4b-404f-97f3-5595406c9db3<div style="text-align: justify;"><img alt="SYNBIO TECH INC. receives patent in The United States for Lactobacillus plantarum TWK10® probiotic strain" src="/ckfinder/userfiles/Images/197012852_m.jpg" style="width: 100%;" /> A leading bio-science company, SYNBIO TECH INC. has gained an important United States patent on one of its most clinically documented probiotic strains named Lactobacillus plantarum TWK10®, which is screened from traditional Taiwanese pickled cabbage. The patent covers the method for improving age-related muscle loss, maintaining or increasing muscle mass and muscle strength in elder subjects. Studies suggest that the gut microbiota affects the host's muscle mass and function by regulating the systemic immune system, anabolism, insulin sensitivity, and energy production, termed the "gut-muscle axis"[1]. The role of the gut-muscle axis has gained tremendous attention in recent years, as the health benefits of probiotics are increasingly being acknowledged as having diverse benefits beyond the gut.  Gut microbiota diversity gradually declines with age and disrupts the gut microbiota balance, promotes systemic inflammation, and causes muscle cell damage, resulting in decreased muscle mass and muscle strength[1]. Scientists at SYNBIO TECH work tirelessly to find the probiotic solution for improving muscle quality and ultimately TWK10® was discovered. In clinical trial, supplementation of Lactobacillus plantarum TWK10® is shown to be able to reduce exercise fatigue-related markers, improve exercise performance[3] and body composition[2] . Furthermore, the result of clinical trial in elderly subjects over the age of 65 showed that supplementation with TWK10® had a tendency to increase and improve muscle mass, left hand grip strength, lower limb muscle strength, gait speed and balance after the sixth week[4].    “We are very pleased with the new patent in the United States. The global silver population is on the rise, the United Nations estimated that by 2050, the population over the age of 65 will reach 1.5 billion, and the elderly population will account for 22% of the global population[5]. And age-related muscle loss affects 100% of the population. Senior population are actively looking into the proactive management of their health putting a great emphasis on prevention not only curing the disease. With robust clinical evidence in improving age-related muscle loss, we are confident that Lactobacillus plantarum TWK10® definitely meets the market needs”, says Mr. Kuei-ming Lee, Vice President at SYNBIO TECH.  “Apart from the United States, Lactobacillus plantarum TWK10® is patented in Japan, Taiwan and patent pending in South Korea. In addition, TWK10® received health claim on improving exercise performance granted by Korean FDA last year. It is very encouraging to experience the acknowledgement of our research and investments in probiotic clinical trials and we are confident that this will pave the way in the probiotic innovation” Lisa Chen, Global Marketing Director at SYNBIO TECH adds. The patent was obtained in the United States on the 13th December 2022 with the patent number US 11,524,038 B2. SYNBIO TECH partners with Lonza Group for the distribution of Lactobacillus plantarum TWK10® in North America and Europe. Reference [1] Giron, M., et al. (2022). Journal of cachexia, sarcopenia and muscle, 13(3), 1460–1476.  [2] Huang, W. C., et al., (2019). Effect of Lactobacillus plantarum TWK10 on exercise physiological adaptation, performance, and body composition in healthy humans. Nutrients, 11(11), 2836.  [3] Huang, W. C., et al., (2018). Effect of Lactobacillus plantarum TWK10 on improving endurance performance in humans. Chin. J. Physiol, 61(3), 163-170.  [4] Lee, M. C., et al., (2021). Lactobacillus plantarum TWK10 improves muscle mass and functional performance in frail older adults: A randomized, double-blind clinical trial. Microorganisms, 9(7), 1466.  [5] World Population Ageing 2019: Highlights. the United Nations.  </div> 生合生物科技有限公司Mon, 10 Apr 2023 00:00:00 GMTSynbio Tech Inc. and Cosmax Group signed an exclusive cooperation agreement to jointly expand the South Korean probiotics markethttps://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=79db560a-0fe8-47a3-9b16-30527bfef24e<img alt="Synbio Tech Inc. and Cosmax Group signed an exclusive cooperation agreement to jointly expand the South Korean probiotics market" src="/ckfinder/userfiles/Images/230131-%e6%96%b0%e8%81%9e%e5%9c%96%e8%a3%bd%e4%bd%9c-%e8%88%87Cosmas%e5%90%88%e4%bd%9c-TWK10%e7%94%a2%e5%93%81-%e8%8b%b1.jpg" style="width: 100%;" /> <div style="text-align: justify;">Kaohsiung, Taiwan, February 1, 2023 Synbio Tech Inc. and Cosmax NBT, a major South Korean biotechnology company officially signed an exclusive cooperation agreement to launch Lactobacillus plantarum TWK10® in South Korea, and announced that TWK10® has been approved as an Individual Health Functional Food certification by the Ministry of Food and Drug Safety of South Korea. Under the agreement, COSMAX NBT will exclusively distribute TWK10® probiotics in muscle health category to meet the growing needs of the active nutrition and healthy aging markets in South Korea.   COSMAX NBT is a subsidiary of COSMAX Group, one of the world's largest research, development and production business group for cosmetic and health functional food products. The company specializes in health care product OEM services, functional food R&D and manufacturing, and is currently a top leading health functional food ODM company in South Korea. KIM SANG WOO, the Vice President of COSMAX NBT says, "According to the market survey report, probiotics are  one of most popular health foods among Koreans like  red ginseng and vitamins, and the market size of probiotics is expected to grow rapidly at an average annual rate of 16%. With Synbio Tech's innovation in R&D and excellent production technology, the partnership will allow us to continuously explore further collaborative projects to bring outstanding products to the South Korean market. "   Lactobacillus plantarum TWK10® is a probiotic strain strictly selected from Taiwanese fermented cabbage. Extensive studies have confirmed that TWK10® has a significant impact on sports performance, muscle mass, and mobility in older adults through the gut-muscle axis. To date, it has 4 human clinical trials, 7 major global patents and more than ten international journal publications. It is Taiwan's first probiotic strain to obtain GRAS Self-affirmed status in the US and obtained Individual Health Functional Food certification in South Korea. This innovative strain is paving the way of probiotic innovation and revolutionizing the nutraceutical and functional food market.   Kuiming Lee, the Vice President of the human health department at Synbio Tech say "This collaboration is a very important milestone for Synbio Tech in becoming a global probiotics manufacturer. With the synergy of Synbio Tech and COSMAX NBT, we will further collaborate in scientific research and market development of TWK10® in South Korea. Looking forward in 2023, TWK10® has gradually completed its global launch and expansion with distribution across different continents including Europe, North America, Japan, South Korea, Southeast Asia and other regions. In the years to come, Synbio Tech will continuously deepen the scientific research of TWK10® and further develop innovative probiotic and postbiotic solutions for better health.</div>   Reference <a href="https://www.nutraingredients-asia.com/Article/2022/03/03/Probiotic-brands-and-retailers-finding-opportunities-with-premium-products-in-Korea" target="_blank">https://www.nutraingredients-asia.com/Article/2022/03/03/Probiotic-brands-and-retailers-finding-opportunities-with-premium-products-in-Korea</a> <a href="http://en.cosmaxnbt.com/" target="_blank">http://en.cosmaxnbt.com/</a>  生合生物科技有限公司Wed, 01 Feb 2023 00:00:00 GMTThe spirit of giving back – From compassion to actionhttps://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=c4012907-f1ed-4ad0-91d1-bda5152504a6“Better probiotics Better Life” goes beyond improving life through better probiotics. Not only impacting society through better probiotics, Synbio Tech collaborates with community–led initiative to improve human health, animal welfare and environmental sustainability with the goal of building stronger, more resilient communities for the long term. <img alt="The spirit of giving back-From compassion to action_Synbio Tech Inc." src="/ckfinder/userfiles/Images/230106-%e7%94%a2%e6%a5%ad%e8%b3%87%e8%a8%8a-CSR%e5%b9%b4%e5%ba%a6%e5%9b%9e%e9%a1%a7_%e5%b7%a5%e4%bd%9c%e5%8d%80%e5%9f%9f%201.jpg" style="width: 100%;" /> <div style="text-align: justify;">  Impacting the local community In collaboration with Luzhu Community Center in Southern Taiwan, in the year of 2022, we were able to support 503 low-income households, benefiting 1,278 individuals through material donations and provided learning devices such as second–hand computers to the students with limited resources. Not only co–working with the community center, Synbio Tech team also show their compassion through donating blood, volunteering at animal welfare service and the coastal cleanup.   Giving blood, saving lives Ensuring a sufficient supply of blood products is a necessary condition for the proper functioning of healthcare and saving lives. Blood donations have dropped at an alarming rate across the globe in the wake of the COVID-19 outbreak. Even regular donors are reluctant to donate blood over the fear of contact and getting infected. Believing that blood donation makes a difference in someone else’s life by giving them a chance to live longer and happier life, this year, 115 donors gave 162 bags of blood to the local blood bank. These generous donors find joy in saving lives through blood donations.   Caring for the furry companions Pet lovers know how much furry companions feel like a part of the family, however, being a pet parent comes with its own set of responsibilities and challenges. A huge number of homeless dogs and cats are struggling to survive on the streets, where they face dangers such as traffic, extreme temperatures, contagious diseases, parasites, and predators. To provide furry friends the care that they need, pet – loving Synbio Tech team generously gave their time at the Kaohsiung Animal Welfare event.  The event advocates responsible pet ownership and provides services for pet neutralizing, chip implantation, pet vaccination and adoption services. Hundreds of pet owners got their furry companions vaccinated and received the care that their furry family needs.   Returning the favor to the ocean The ocean-loving Synbio Tech team took to the shore to the Southern beach to clean and preserve the beautiful coastline and protect marine lives. Beach clean-ups are vital to mitigate the problem caused by ocean debris and the danger that plastic pollution poses to marine life and organisms which provide nutrients to the sea, and make the ecosystem healthier. During the beach clean-up, we collected approximately 100 Kg of trash. The most dominant litter were cigarette buds, straws, plastic bags, foam pieces, glass bottles, beer cans, food packaging wraps, and fishing gear.   We are truly appreciative of Synbio Tech team for their time and effort in making positive impacts on human health, animal health and the environment. As a team, we are constantly striving to build a better community, working together to improve lives locally as well as globally. </div>  生合生物科技有限公司Tue, 10 Jan 2023 00:00:00 GMTSynbio Tech Inc. Won Product Innovation Awards of Taiwan Association for Lactic Acid Bacteriahttps://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=e694f9b5-83df-440b-b2af-b9632e6cc7b4<div style="text-align: justify;">Synbio Tech Inc. has received the Innovative Product Award for its products, heat-killed Lactobacillus kefiranofaciens M1 and SYNPETTM TRENAL from Taiwan Association for Lactic Acid Bacteria (TALAB). These two products stand out among the competitors due to their innovativeness, robust science and potential commercial success.</div> <img alt="Lactobacillus kefiranofaciens M1 is the most superior strain selected from Mongolian kefir." src="/ckfinder/userfiles/Images/221227-%e5%8f%b0%e7%81%a3%e4%b9%b3%e9%85%b8%e8%8f%8c%e5%8d%94%e6%9c%83111%e5%b9%b4%e5%ba%a6%e5%89%b5%e6%96%b0%e7%94%a2%e5%93%81%e7%8d%8e%e7%8d%b2%e7%8d%8e-M1-EN_%e5%b7%a5%e4%bd%9c%e5%8d%80%e5%9f%9f%201.jpg" style="width: 100%;" />   <div style="text-align: justify;">Lactobacillus kefiranofaciens M1 is the most superior strain selected from Mongolian kefir. Heat–inactivated bacteria, postbiotics are the hottest trend in the nutraceutical world today. Due to its unique health benefits and flexibility in terms of application, M1 has been widely appreciated by the customers in Taiwan as soon as it was launched, it also sparks interest among international partners and customers. Experimental results showed that M1 has a tendency to regulate Th1/Th2 immune balance and total IgE concentration in serum, and has the potential to reduce airway resistance, inflammation and improve allergic rhinitis and asthma.</div>   <img alt="SYNPETTM is a series of pet health functional products developed in collaboration with academic institutions and experts over the years " src="/ckfinder/userfiles/Images/221227-%e5%8f%b0%e7%81%a3%e4%b9%b3%e9%85%b8%e8%8f%8c%e5%8d%94%e6%9c%83111%e5%b9%b4%e5%ba%a6%e5%89%b5%e6%96%b0%e7%94%a2%e5%93%81%e7%8d%8e%e7%8d%b2%e7%8d%8e-SYNPET%20TRENAL-EN_SYNPET%20TRENAL.jpg" style="width: 100%;" /> <div style="text-align: justify;"> SYNPETTM is a series of pet health functional products developed in collaboration with academic institutions and experts over the years and finally launched in July, 2022. It is a brand new probiotic solution for furry companions which has been validated by animal science and clinical trials. Clinical evidence demonstrated that SYNPETTM TRENAL help maintain kidney function, promote circulation in the body and metabolize harmful substances. It can be used as a daily kidney care supplement.    Synbio Tech not only makes substantial R&D investments every year, but also continuously improves its production capabilities and quality control for the technological and product innovation. The functional postbiotic M1 and the pet probiotic, SYNPETTM TRENAL winning the innovative awards acknowledge and recognize Synbio Tech's dedication towards research and development of probiotics and postbiotics which meets the customer's needs.</div>  生合生物科技有限公司Fri, 30 Dec 2022 00:00:00 GMTSynbio reading day: Keep calm and let's read!https://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=4efbcef1-815c-496d-b7f3-5ba62a2fa069<img alt="Synbio reading day: Keep calm and let's read!" src="/ckfinder/userfiles/Images/S__70377511-%E8%AA%BF%E8%89%B2.jpg" style="width: 100%;" /> <div style="text-align: justify;"> Reading is to the mind what exercise is to the body! As part of our annual book donation, the book of the year 2022 is "The Untethered Soul: The Journey Beyond Yourself" by Michael Alan Singer.   What can you do each day to discover inner peace? The Untethered Soul offers simple yet profound answers to this question. By tapping into meditation and mindfulness, the author shows how the development of consciousness enable us to live in the present and let go of painful thoughts and memories that keep us from true happiness and self-realization.   We hope you will read with us and discover inner peace.  </div> 生合生物科技有限公司Fri, 25 Nov 2022 00:00:00 GMTTWK10® muscle probiotics: A new stage of opportunity in healthy aginghttps://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=245b9ac5-9543-4c99-b6fe-659e8214b955<img alt="TWK10® muscle probiotics: A new stage of opportunity in healthy aging" src="/ckfinder/userfiles/Images/116270762_m.jpg" style="width: 100%;" /> Living longer: Silver generation, golden opportunity! <div style="text-align: justify;">Thanks to the advancement of medical technology and better living conditions, we all live longer and resulting in accelerated aging of the population. In fact, the United Nations estimated that by 2050, the population over the age of 65 will reach 1.5 billion, and the elderly population will account for 22% of the global population[9]. However, increased life expectancy does not necessarily mean improved healthy life expectancy, but it comes with various aging-related health issues. Healthy aging has become a major nutraceutical trend as the global senior population is growing. The study suggests that senior population are actively looking into the proactive management of their health putting a great emphasis on prevention not merely curing the disease. They are seeking solutions to live better as they age and they see taking supplements as one possible option to improve the sign of aging, as a result, clinically validated high quality supplements are in high demand. Research suggests that the older adults’ health supplements market is projected to reach US$ 265 Billion by 2032 with a CAGR of 6% from 2021 to 2032[2].</div>   Skeletal muscle: An important indicator of "Aging" Among aging-associated disorders, the most common issue is that muscle mass and strength gradually decline during the aging process [4].Skeletal muscle is the most important organ affecting human metabolism and energy reservation, accounting for more than 40% of body weight [5]. The “mass, quality and strength” of skeletal muscle begin to lose at high speed after mid-life age, decline at a rate of between 1% and 2% per year from the age of 50, 1.5% per year from the age of 50–60, and 3% per year thereafter, thereby significantly increasing the risk of falls, cognitive impairment, morbidity, disability, and mortality[1][7]. This degenerative loss accompanies aging and reduced functional activity is known as "sarcopenia"[7]. As the population ages, muscle health has become an ever-increasing concern and is expected to be a significant focus for future supplement development.   New probiotics concept: gut-muscle axis Studies have found that the gut microbiota affects the host's muscle mass and function by regulating the systemic immune system, anabolism, insulin sensitivity, and energy production, termed the "gut-muscle axis"[3]. During the aging process, the diversity of gut microbes gradually declines, which disrupts the gut microbiome balance, promotes systemic inflammation, and causes muscle cell damage, resulting in decreased muscle mass and muscle strength[3]. Probiotics supplementation seems to be one of the most effective ways to increase and change the proportion and distribution of gut microbiota[6].     Clinically validated solution for muscle loss A clinical study published in the Journal of Microorganisms in 2021 found that after taking TWK10® for 18 consecutive weeks, 42 elderly subjects aged 55 - 85 with mild fragility were greatly shown to improve muscle mass, grip strength and lower limb strength. Furthermore, the speed of walking and the stability of standing were also significantly improved [6]. Based on the remarkable clinical evidence, vegan and naturally sourced TWK10®  is a promising ingredient for healthy aging supplements to enhance muscle strength and reduce physical fragility and the risk of sarcopenia. With clinically validated efficacy and a flexible delivery format, brands may seize the golden opportunity by helping the silver generation stay healthy and happy as they age.   Reference [1] Dawson, A., & Dennison, E. (2016). Maturitas, 93, 13-17. [2] Future Market Insights. (2021). Older Adults Health Supplements Market Overview (2022-2032). Future Market Insights. Retrieved July 13, 2022, from https://www.futuremarketinsights.com/reports/older-adults-health-supplements-market [3]Giron, M., et al. (2022). Journal of cachexia, sarcopenia and muscle, 13(3), 1460–1476. https://doi.org/10.1002/jcsm.12964 [4] Keller, K., & Engelhardt, M. (2013). Muscles, ligaments and tendons journal, 3(4), 346. [5] Kim, K. M., Jang, H. C., & Lim, S. (2016). The Korean journal of internal medicine, 31(4), 643–650. [6] Lee, M. C., et al. (2021). Microorganisms, 9(7), 1466. [7] Larsson, L., et al. (2019). Physiological reviews, 99(1), 427–511.World Population Ageing 2019: Highlights. the United Nations. [8] World Population Ageing 2019: Highlights. the United Nations. <span style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; line-height: inherit; font-family: "Microsoft Jhenghei", 微軟正黑體, "Trebuchet MS", Arial, Helvetica, sans-serif; vertical-align: baseline; color: rgb(59, 59, 59);">Disclaimer <div style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: 16px; line-height: inherit; font-family: "Microsoft Jhenghei", 微軟正黑體, "Trebuchet MS", Arial, Helvetica, sans-serif; vertical-align: baseline; color: rgb(59, 59, 59); text-align: justify;"><span style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; font-family: inherit; vertical-align: baseline;">The information contained herein is based on data known to SYNBIO TECH by their own research and development work and is, to the best of our knowledge, reliable. This sharing of business-to-business information is intended for the general discussion between food and supplement enterprises only, and is not intended for final consumer. The information is provided at “as is” basis and its use is at the recipient’s sole discretion and risk.  Information and statements herein shall not be construed as licenses to practice, or recommendations to infringe, any patents or other intellectual property rights of SYNBIO TECH or others. SYNBIO TECH hereby expressly disclaims (I) any and all liability in connection with such information, including, but not limited to, any liability relating to the accuracy, completeness, or usefulness of such information, and (II) any and all representations or warranties, express or implied, with respect to such information, or any part thereof, including all representations and warranties of title, non-infringement of copyright or patent rights of others, merchantability, fitness or suitability for any purpose, and warranties arising by law, statute, usage of trade or course of dealing. For more information, please contact: <a href="mailto:service@synbiotech.com.tw" style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; font-size: 8px; line-height: inherit; font-family: inherit; vertical-align: baseline; text-decoration-line: none; outline: none !important;">service@synbiotech.com.tw</a><span style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; line-height: inherit; font-family: inherit; vertical-align: baseline;"> or <a href="http://www.synbiotech.com/" style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; font-size: 8px; line-height: inherit; font-family: inherit; vertical-align: baseline; text-decoration-line: none; outline: none !important;" target="_blank">www.synbiotech.com</a>  </div> 生合生物科技有限公司Mon, 25 Jul 2022 00:00:00 GMTSynbio Tech Inc. held a new plant groundbreaking ceremony in Kaohsiung Science Park, Taiwanhttps://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=99def212-7ee9-4660-aa1f-efeb92665a23Written by: Lisa Chen, Marketing Director <img alt="" src="/ckfinder/userfiles/Images/%E7%94%9F%E5%90%88%E7%94%9F%E7%89%A9%E5%8B%95%E5%9C%9F%E5%85%B8%E7%A6%AE.jpg" style="width: 100%;" /> <div style="text-align: justify;"> Breaking first ground for their new plant in Kaohsiung Science Park, Synbio Tech is heralding the next stage of their business activities in the international market. Celebrated on the 27th February 2022, the new plant groundbreaking ceremony kicked off the construction of a plant that will produce quality probiotics and postbiotics for human health, animal health and agriculture.   In recent years, domestic and international demand for Synbio Tech's probiotic products has contributed to record high sales. Thanks to its revolutionary probiotic strain, Lactobacillus plantarum TWK10® and collaboration with Lonza Group, Synbio Tech's business activities flourish in international market which prompted the company takes this next step of building a new plant. Synbio Tech is pouring an investment of approximately $ 67 million (US Dollar) into the new plant and its new and highly advanced production lines to accommodate the increasing demand from the local and international markets.   “The new plant will integrate the green construction concept and efficient production lines to improve the quality and efficiency. In addition, with the plan of appliying the "Green Building Label" certification, the new plant will be the backbone for our global business expansion.” said Mr. Yang, CEO of Synbio Tech Inc., commenting on the groundbreaking for the plan.   “With the increasing awareness of the vital role of gut microbes, we are optimistic about the application and demand of lactic acid bacteria in various business areas.  The production line of our new factory will be focused on three major directions: raw bacteria powder for health care, lactic acid bacteria for agriculture and animal husbandry, and postbiotic solutions. Furthermore, in addition to the upgrade of hardware and equipment, the new plant will set up a new strain R&D center to enhance the R&D capacity of lactic acid bacteria and intestinal microbes” added Sean Yang, the General Manager of Synbio Tech Inc.    With the industry-leading R&D achievements and production technology of lactic acid bacteria, Synbio Tech is continuously exploring high-quality and diverse probiotic products for human & animal health, agricultural, and environmental protection.   About Synbio Tech Inc. Synbio Tech specializes the research, development and manufacturing of lactic acid bacteria by utilizing microbiome genomics and "SYNTEK® thorough" core technology to deepen the depth and breadth of the lactic acid bacteria application in various fields.</div>  生合生物科技有限公司Tue, 08 Mar 2022 00:00:00 GMTPostbiotics: The hottest trend in 2022?https://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=11373c8c-b770-4d70-9ce1-7a5d22cc94da<img alt="Postbiotics: The hottest trend in 2022?" src="/ckfinder/userfiles/Images/220224-%e7%94%a2%e6%a5%ad%e8%b3%87%e8%a8%8a-%e5%be%8c%e7%94%9f%e5%85%83(Postbiotics)%ef%bc%9f2022%e4%bd%a0%e4%b8%80%e5%ae%9a%e8%a6%81%e4%ba%86%e8%a7%a3%e7%9a%84%e8%b6%a8%e5%8b%a2-EN_%e5%b7%a5%e4%bd%9c%e5%8d%80%e5%9f%9f%201.jpg" style="width: 100%;" /> <div style="text-align: justify;"> In the midst of a global pandemic, an increasing number of consumers are seeking food and beverages that offer better health benefits. There is growing consumer awareness of postbiotics, according to Lumina Intelligence, postbiotics have become the fastest growing area in terms of gut health Google searches, with a nearly 1,300% increase from 2019 to 2021 [4].</div>   <div style="text-align: justify;">Prebiotics, probiotics, synbiotics have been widely used in the “biotics” field, however, the term “postbiotics” has greatly attracted attention from academia and industry in recent years. With the development of postbiotics research, it seems to revolutionize the nutraceutical industry.</div>   What are postbiotics? <div style="text-align: justify;">Postbiotics are undoubtedly the most discussed topic in the nutraceutical industry nowadays. The term 'postbiotics' is increasingly found in the scientific literature and commercial products. Common postbiotics include nutrients such as vitamins B and K, amino acids, and substances called antimicrobial peptides which inhibit pathogen growth, and post-biomass such as short-chain fatty acids help healthy gut bacteria thrive [2][5].   In response to the increasing use of the term "postbiotics" in scientific literature and commercial products, the International Association for the Science of Probiotics and Prebiotics (ISAPP) defined postbiotics as “preparation of inanimate microorganisms and/or their components that confers a health benefit on the host” [5].</div>   Why is the postbiotics gaining huge attention? <div style="text-align: justify;">Postbiotics play a vital role in the immune system. They not only improve the protection of the immune barrier but also improve the composition of intestinal flora. Research demonstrated that postbiotics have immune regulation, anti-inflammatory, antioxidant and anti-hypertensive properties. It also has the functions of directly regulating immunity, improving overall health and relieving the symptoms of various diseases [1][3]. Moreover, the scientific community is constantly discovering further postbiotic applications for other health benefits.</div>   <div style="text-align: justify;">In addition, postbiotics are inactivated microorganisms. They are more stable than probiotics, which is sensitive to temperature and not easy to store. Therefore, they not only break through the limitations of probiotics but also expands the flexibility of product applications, such as beverages, baked goods, lozenge dietary supplements that would otherwise be unsuitable for live bacteria [6].</div>   Innovative postbiotic solutions <div style="text-align: justify;">As Synbio Tech thrives to advance scientific research to promote better health, Synbio Tech will be launching two functional postbiotic products this year with anti-asthmatic allergy and joint health benefits. We are continuously exploring probiotic and postbiotic solutions in fulfilling our mission “Better Probiotics, Better Life”.</div> Reference [1] Carrie A M Wegh , Jan Knol , Guus Roeselers , Clara Belzer , “Postbiotics and Their Potential Applications in Early Life Nutrition and Beyond,” Int J Mol Sci, p. 20(19):4673, 2019. [2] Golen, T., & Ricciotti, H. (2021,). What are postbiotics? Harvard Health Publishing. Retrieved February 24, 2022, from https://www.health.harvard.edu/nutrition/what-are-postbiotics [3] Jakub Żółkiewicz , Aleksandra Marzec , Marek Ruszczyński , Wojciech Feleszko, “Postbiotics—A Step Beyond Pre- and Probiotics,” Nutrients 2020, pp. 12(8), 2189, 2020. [4] Lumina Intelligence, Postbiotics: Consumer interest surges in 2 years [5] Seppo Salminen et al., “The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics,” Nature Reviews Gastroenterology & Hepatology, p. 18, 2021. [6] W. Chu, “Probiota 2022: Pondering on all things postbiotic…,” 2022. [Online]. Available: https://cutt.ly/zPVrPCg. <span style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: 8px; line-height: inherit; font-family: "Microsoft Jhenghei", 微軟正黑體, "Trebuchet MS", Arial, Helvetica, sans-serif; vertical-align: baseline; color: rgb(59, 59, 59);">Disclaimer <div style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: 16px; line-height: inherit; font-family: "Microsoft Jhenghei", 微軟正黑體, "Trebuchet MS", Arial, Helvetica, sans-serif; vertical-align: baseline; color: rgb(59, 59, 59); text-align: justify;"><span style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; font-size: 8px; line-height: inherit; vertical-align: baseline;">The information contained herein is based on data known to SYNBIO TECH by their own research and development work and is, to the best of our knowledge, reliable. This sharing of business-to-business information is intended for the general discussion between food and supplement enterprises only, and is not intended for final consumer. The information is provided at “as is” basis and its use is at the recipient’s sole discretion and risk.  Information and statements herein shall not be construed as licenses to practice, or recommendations to infringe, any patents or other intellectual property rights of SYNBIO TECH or others. SYNBIO TECH hereby expressly disclaims (I) any and all liability in connection with such information, including, but not limited to, any liability relating to the accuracy, completeness, or usefulness of such information, and (II) any and all representations or warranties, express or implied, with respect to such information, or any part thereof, including all representations and warranties of title, non-infringement of copyright or patent rights of others, merchantability, fitness or suitability for any purpose, and warranties arising by law, statute, usage of trade or course of dealing. For more information, please contact: <a href="mailto:service@synbiotech.com.tw" style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; font-size: 8px; line-height: inherit; vertical-align: baseline; text-decoration-line: none; outline: none !important;">service@synbiotech.com.tw</a><span style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; font-size: 8px; line-height: inherit; vertical-align: baseline;"> or <a href="http://www.synbiotech.com/" style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-style: inherit; font-variant: inherit; font-weight: inherit; font-stretch: inherit; font-size: 8px; line-height: inherit; vertical-align: baseline; text-decoration-line: none; outline: none !important;" target="_blank">www.synbiotech.com</a>  </div> 生合生物科技有限公司Fri, 25 Feb 2022 00:00:00 GMT【New year, new solutions!】https://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=1905efd8-5ef4-4a55-95b4-5adf0968a305Embracing our core value, “Better probiotics, better life”, Synbio Tech is thriving every year investing on scientific research to advance human health through probiotic solutions. This new year 2022, we are bringing you probiotic and postbiotic solutions focusing on allergic rhinitis, allergic asthma, joint health and healthy aging. Let us know how we can help you create your next cutting-edge products with science-backed probiotic and postbiotic solutions. <img alt="New year, new solutions! SYNBIO TECH" src="/ckfinder/userfiles/Images/220124-%e9%9b%bb%e5%ad%90%e5%a0%b1%e7%94%a8%e5%9c%96-What%20is%20new%20at%20Synbio%20Tech%20in%202022-Other%20regions_01.jpg" style="width: 100%;" /> <img alt="" src="/ckfinder/userfiles/Images/220124-%e9%9b%bb%e5%ad%90%e5%a0%b1%e7%94%a8%e5%9c%96-What%20is%20new%20at%20Synbio%20Tech%20in%202022-Other%20regions_02.jpg" style="width: 100%;" /> <img alt="" src="/ckfinder/userfiles/Images/220124-%e9%9b%bb%e5%ad%90%e5%a0%b1%e7%94%a8%e5%9c%96-What%20is%20new%20at%20Synbio%20Tech%20in%202022-Other%20regions_03.jpg" style="width: 100%;" /> <img alt="" src="/ckfinder/userfiles/Images/220124-%e9%9b%bb%e5%ad%90%e5%a0%b1%e7%94%a8%e5%9c%96-What%20is%20new%20at%20Synbio%20Tech%20in%202022-Other%20regions_04.jpg" style="width: 100%;" /> <img alt="" src="/ckfinder/userfiles/Images/220124-%e9%9b%bb%e5%ad%90%e5%a0%b1%e7%94%a8%e5%9c%96-What%20is%20new%20at%20Synbio%20Tech%20in%202022-Other%20regions_05.jpg" style="width: 100%;" /> <img alt="" src="/ckfinder/userfiles/Images/220124-%e9%9b%bb%e5%ad%90%e5%a0%b1%e7%94%a8%e5%9c%96-What%20is%20new%20at%20Synbio%20Tech%20in%202022-Other%20regions_06.jpg" style="width: 100%;" />  生合生物科技有限公司Thu, 27 Jan 2022 00:00:00 GMTLooking back with gratitude, looking forward with hopehttps://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=ffe811df-b5f2-44db-9d11-95524276a660<img alt="" src="/ckfinder/userfiles/Images/2112224-%e9%9b%bb%e5%ad%90%e5%a0%b1%e7%94%a8%e5%9c%96-%e5%b9%b4%e7%b5%82%e5%95%8f%e5%80%99%e6%84%9f%e8%ac%9d%e4%bf%a1-EN_%e5%b7%a5%e4%bd%9c%e5%8d%80%e5%9f%9f%201.jpg" style="width: 100%;" />  生合生物科技有限公司Fri, 24 Dec 2021 00:00:00 GMTOur commitment: Better community, better life!https://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=d38b722f-80ac-433f-9804-3a0dd02d30b6<img alt="Our commitment: Better community, better life!" src="/ckfinder/userfiles/Images/211022-%e9%9b%bb%e5%ad%90%e5%a0%b1%e7%94%a8%e5%9c%96-%e6%85%88%e5%96%84%e8%a1%8c%e5%8b%95%e5%88%86%e4%ba%ab-EN_%e5%b7%a5%e4%bd%9c%e5%8d%80%e5%9f%9f%201.jpg" style="width: 100%;" /> Our DNA <div style="text-align: justify;">“Better probiotics, better life”, promoting the quality of life is the core of everything we do at Synbio Tech. In implementing our vision, improving the quality of all lives, Synbio Tech is committed to caring for the local community since its founding, constantly giving back to the community and creating a positive impact. Caring for the people is so tightly woven into Synbio Tech's DNA, with every activity in alignment with the company statute. Keeping our company values front of mind is a key driver for everything we do and we preoccupy ourselves with ensuring we are living up to our words. </div> Impacting local community  <div style="text-align: justify;">Synbio Tech has been helping vulnerable communities for years with support for basic needs such as food, nutritional supplies, and daily use items by collaborating with community-led initiatives.  We are responding to help those in urgent need while continuing to build stronger, more resilient communities for the long term. In doing so, Synbio Tech make material assistance donations to vulnerable communities in Luzhu District, Kaohsiung, Taiwan annually by collaborating with Luzhu Social Welfare Center. This initiative contributes to the family emergency relief, the disadvantaged groups, and assisting the group which has been excluded by the social welfare system by helping them access basic needs such as food items, nutritional supplies and care supplies. More than 1000 lives have been positively impacted in the year 2021, this initiative helps people to access to the supports they need the most. Through initiative like this, we proactively enforce our community caring aspirations, many lives in Luzhu have been positively impacted because of this initiative. When the COVID-19 pandemic hit, efforts to support such needs became even more essential.  </div> Better life <div style="text-align: justify;">Through this initiative, people's basic needs are met, lives are enhanced and hope is conveyed.  “Better probiotics, better life” goes beyond improving life through better probiotics, it also means making a difference in the lives of those who are the most disadvantaged in the community by helping them to have access to basic needs,” says Lian Chwan Yang, Chief Executive Officer of Synbio Tech When businesses or organizations partner with Synbio Tech., they are also helping to improve lives and build a better community, working together to improve lives locally as well as globally.   </div> <div style="text-align: center;">Better probiotics, better community, better life!  </div> 生合生物科技有限公司Mon, 25 Oct 2021 00:00:00 GMTSynForU ™-HerCare: Empowering “HER” with science-backed probioticshttps://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=82f883ba-a00c-4c18-8943-30ffa0a2eb23<div style="text-align: center;"><img alt="SynForU ™-HerCare: Empowering “HER” with science-backed probiotics" src="/ckfinder/userfiles/Images/210916-%e9%9b%bb%e5%ad%90%e5%a0%b1%e7%94%a8%e5%9c%96-SynForU_%20HerCare-EN_%e5%b7%a5%e4%bd%9c%e5%8d%80%e5%9f%9f%201.jpg" style="width: 100%;" /></div> Vaginal infections: More than just physical health issue <div style="text-align: justify;">Vaginal infections represent a unique health challenge for women, with one billion women worldwide troubled by vaginal infections and UTIs annually(7). Discomforting symptoms leading to frequent hospital visits, the estimated annual global economic burden of the treatment of vaginal infections costs US $4.8 billion(5), affecting not merely physical health but also emotional and social well-being of women such as worry about the symptoms and suffering from lack of confidence in social interaction. The most common treatment for vaginal infections to date is antifungal drugs. However, these drugs come with drawbacks such as increased recurrence rate and drug resistance.</div> LACTOBACILLI: The key to a healthy vagina <div style="text-align: justify;">The healthy vagina is primarily colonized with the genus Lactobacillus, which is the most abundant bacteria, accounting for more than 95% of the microorganisms in the vagina. Lactobacilli serve as a gatekeeper to maintain vaginal health by decomposing the glycogen into lactic acid and hydrogen peroxide (H2O2), acidify the vagina environment with lactic acid. In addition, lactobacilli adhere to the vaginal epithelial cells and inhibit the growth of pathogens, thereby helps maintain the balance of the vaginal flora and improve vaginal health(1). Decreased amount of lactobacilli in the vaginal microbiota is associated with increased disease risk.</div>   SCIENCE: The key to success in women's healthcare market <div style="text-align: justify;">As women continue to seek ways to improve their well-being, the global women's healthcare market is rising sharply, the market was worth USD 31.04 billion in 2019 and is expected to reach USD 45.31 billion in 2027(3). Furthermore, increasing numbers of women are seeking science-backed natural solutions for supporting their everyday well-being. In light of this, probiotics could present as the optimal solution.   As science continues to shed light on the critical role of probiotics in wellbeing, probiotic consumption continues to grow, the global probiotics market is projected to be worth USD 91.1 billion by 2026, growing at a CAGR of 8.3%(6). Furthermore, study suggests that probiotics could even substitute pharmaceutical agents(6). However, today’s consumers are more informed and connected than ever before. Study suggests that 39% of global consumers are more likely buy a healthy lifestyle product if its claims are based on scientific data(4). Therefore, incorporating science-backed probiotics is the key to differentiation and staying ahead of competition in women's healthcare market.</div>   The Science behind SynForU™-HerCare <div style="text-align: justify;">With longstanding expertise in probiotics research, Synbio Tech. has developed an innovative solution to help women battling with vaginal candidiasis (VC). SynForU™-HerCare is clinically validated probiotics incorporating six patented Lactobacilli strains (LA25, LDL114, LP115, LF26, LRH10, LPC12). The study published in the Journal of Applied Microbiology investigated the effects of SynForU™-HerCare in 78 pregnant women with VC(2). The results show that SynForU™-HerCare not only improves the physical health aspect, it also improves the emotional well-being of the participants(2). SynForU™-HerCare shows:</div> <ul> <li>45% reduction of vulvovaginal symptoms such as irritation, discharge, and burning</li> <li>34.6% reduction of the impairment of daily activities attributed to VC</li> <li>11% increase in defecation times</li> <li>38% decrease in recurrences of emotional stress</li> </ul> <div style="text-align: justify;">With robust scientific evidences, SynForU™-HerCare helps the brands to stand out in the women's healthcare market while empowering women by providing holistic support to their everyday well-being. SynForU™-HerCare is our commitment to providing long-term care for women around the globe, thereby making a difference in their life.</div> Reference: <div style="text-align: justify;">[1] Amabebe, E., & Anumba, D. (2018). The Vaginal Microenvironment: The Physiologic Role of Lactobacilli. Frontiers in medicine, 5, 181. [2] Ang, X. Y., Chung, F. Y., Lee, B. K., Azhar, S., Sany, S., Roslan, N. S., Ahmad, N., Yusof, S. M., Abdullah, N., Nik Ab Rahman, N. N., Abdul Wahid, N., Deris, Z. Z., Oon, C. E., Wan Adnan, W. F., & Liong, M. T. (2021). Lactobacilli Reduce Recurrences of Vaginal Candidiasis in Pregnant Women: A Randomized, Double-Blind, Placebo-Controlled Study. Journal of applied microbiology, 10.1111/jam.15158. [3] Global Women's Health Market Size. (2020). Verified Market Research. [4] Kerry Global Consumer Survey – Digestive & Immune Health, 2019 [5] Peebles, K., Velloza, J., Balkus, J. E., McClelland, R. S., & Barnabas, R. V. (2019). High global burden and costs of bacterial vaginosis: a systematic review and meta-analysis. Sexually transmitted diseases, 46(5), 304-311. [6] Probiotics market - Global forecast to 2026, MarketsandMarkets. [7] Reid G, Bruce AW. Urogenital infections in women: can probiotics help? Postgrad Med J. 2003;79(934):428-432.</div> <span style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: 8px; line-height: inherit; font-family: "Microsoft Jhenghei", 微軟正黑體, "Trebuchet MS", Arial, Helvetica, sans-serif; vertical-align: baseline; color: rgb(59, 59, 59);">Disclaimer <div style="text-align: justify;"><span style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: 8px; line-height: inherit; font-family: "Microsoft Jhenghei", 微軟正黑體, "Trebuchet MS", Arial, Helvetica, sans-serif; vertical-align: baseline; color: rgb(59, 59, 59);">The information contained herein is based on data known to SYNBIO TECH by their own research and development work and is, to the best of our knowledge, reliable. This sharing of business-to-business information is intended for the general discussion between food and supplement enterprises only, and is not intended for final consumer. The information is provided at “as is” basis and its use is at the recipient’s sole discretion and risk.  Information and statements herein shall not be construed as licenses to practice, or recommendations to infringe, any patents or other intellectual property rights of SYNBIO TECH or others. SYNBIO TECH hereby expressly disclaims (I) any and all liability in connection with such information, including, but not limited to, any liability relating to the accuracy, completeness, or usefulness of such information, and (II) any and all representations or warranties, express or implied, with respect to such information, or any part thereof, including all representations and warranties of title, non-infringement of copyright or patent rights of others, merchantability, fitness or suitability for any purpose, and warranties arising by law, statute, usage of trade or course of dealing. For more information, please contact: <a href="mailto:service@synbiotech.com.tw" style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: 8px; line-height: inherit; font-family: "Microsoft Jhenghei", 微軟正黑體, "Trebuchet MS", Arial, Helvetica, sans-serif; vertical-align: baseline; text-decoration-line: none; outline: none !important;">service@synbiotech.com.tw</a><span style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: 8px; line-height: inherit; font-family: "Microsoft Jhenghei", 微軟正黑體, "Trebuchet MS", Arial, Helvetica, sans-serif; vertical-align: baseline; color: rgb(59, 59, 59);"> or <a href="http://www.synbiotech.com/" style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: 8px; line-height: inherit; font-family: "Microsoft Jhenghei", 微軟正黑體, "Trebuchet MS", Arial, Helvetica, sans-serif; vertical-align: baseline; text-decoration-line: none; outline: none !important;" target="_blank">www.synbiotech.com</a></div>  生合生物科技有限公司Wed, 22 Sep 2021 00:00:00 GMTSynForU™-HerCare probiotics shows benefits to reduce vaginal yeast infection in pregnant women https://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=e1946092-3f91-4c64-a3dd-34b25ec7afc5<img alt="" src="/ckfinder/userfiles/Images/48105417_s.jpg" style="width: 1398.89px;" /> <div style="text-align: justify;">The first clinical study which has been published in the Journal of Applied Microbiology documents that SynForU™-HerCare is effective in reducing vulvovaginal symptoms and recurrences of vaginal candidiasis (VC) in pregnant women.   SynForU™-HerCare, lactobacilli strains, is designed to improve the quality of life in pregnant women with vaginal candidiasis (VC), one of the most common health issues affecting women globally. It is a combination of six probiotic strains isolated from dairy, namely Lactobacillus plantarum LP115, Lactobacillus helveticus LA25, Lactobacillus rhamnosus LRH10, Lactobacillus paracasei LPC12, Lactobacillus fermentum LF26, and Lactobacillus delbrueckii subsp. lactis LDL114. This probiotic blend has been tested to ensure its quality, efficacy and performance. It is superior in adhesive ability to Hela cell, hydrogen peroxide production, and antibacterial activity compared to other intimate care probiotics in the market.   “Most researches on probiotics and vaginal candidiasis (VC) primarily emphasized on women in general, without specifically targeting pregnant women. While VC may occur randomly in pregnant women; however, studies indicate that a higher prevalence was observed in pregnant women regardless of their age, trimester, parity, occupation and educational levels. When it comes to VC treatment, studies suggest that probiotics are preferred option compared to antifungal drugs because these drugs normally come with side effects such as increased recurrence rate and drug resistance. Thus, we developed further randomized studies to investigate the potential impact of probiotics on prevention of VC particularly in pregnant women.” says Dr. San Land Young, Human Healthcare Global Operation Head of Synbio Tech.   Seventy-eight subjects at 14-32 weeks of pregnancy with VC, completed the double-blind, placebo-controlled randomized 8-week study. The intervention group took lactobacilli probiotics, (two capsules/ day of 9.5 log CFU/ capsule) for 8 weeks.   The lactobacilli group shows 45% reduction of vulvovaginal symptoms such as irritation, discharge and burning (P<0.05), 31% reduction of worry (P=0.001), 34.6% reduction of the impairment of daily activities attributed to VC at week-8 (P=0.026) whereas the placebo group showed no significant changes in emotional stress or in social impacts. Notably, the lactobacilli group also reported 38% decreasing in recurrences of emotional stress at week-8 (P=0.0002 Vs P=0.003) and 33% improvement in social impacts (P=0.006) compared to the placebo group. In addition, the lactobacilli group also demonstrated higher defecation times per week (11% increase) (P=0.001) and showed marginally less constipated (P=0.06) as compared to the placebo group. The results indicate that supplementation of SynForU™-HerCare reduces vulvovaginal symptoms, recurrences of VC, and improve emotional and social distress attributed to VC. Moreover, SynForU™-HerCare showed the potential benefit in reducing risks of pregnancy-induced constipation. Women can benefit from compelling effects of SynForU™-HerCare, efficacious and science-supported probiotics. SynForU™-HerCare is available worldwide now. Lisa Chen, Marketing Manager at Human Healthcare, Synbio Tech commented that “There are many probiotics with claims in the market, but science is the key. SynForU™-HerCare is backed by robust science and it is our commitment to providing long-term care for women around the globe, thereby make a difference in their life”.</div>     About Synbio Tech.   <div style="text-align: justify;">Synbio Tech is a global partner for supplying a broad range of probiotic solutions to the nutraceutical, biotech and specialty ingredients markets. We work to promote a healthier world by enabling our customers to deliver innovative nutraceuticals, functional foods and dietary supplements to help improve the quality of life. For more information, please visit: https://www.synbiotech.com</div>   Synbio Tech contact detail Marketing Manager, Human Healthcare lisa.chen@synbiotech.com.tw     Reference J Appl Microbiol. 2021 May 22.  doi: 10.1111/jam.15158. Click below to read in different languages  生合生物科技有限公司Tue, 31 Aug 2021 00:00:00 GMTThe power of KOUMISS magichttps://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=85361542-87f9-462f-a85e-c6348a6e9425<img alt="SynForU-HepaAid Protective care for Liver" src="/ckfinder/userfiles/Images/210820-%e9%9b%bb%e5%ad%90%e5%a0%b1%e7%94%a8%e5%9c%96-SynForU_%20HepaAid-EN_%e5%b7%a5%e4%bd%9c%e5%8d%80%e5%9f%9f%201.jpg" style="width: 100%;" /> Liver health: a global concern <div style="text-align: justify;">The liver plays a vital role in the metabolism of nutrients, synthesis of glucose and lipids, and detoxification of drugs and xenobiotics which is taken. However, the liver bears heavy burdens due to lifestyle habits such as frequent drinking and diets high in processed food. According to the World Health Organization, nearly 330 million people worldwide die from alcohol abuse every year (7), and heavy drinking has become an alarming issue among the youth in developed nations (4). Indeed, liver health is a concerning issue, studies suggest that alcoholic liver disease, which ranges from mild disease to alcoholic hepatitis and cirrhosis, is a leading cause of morbidity and mortality (3).</div>   The impact of excessive drinking on gut-liver axis <div style="text-align: justify;">The liver is the main metabolic organ of the human body, it provides storage space for important nutrients such as glucose, iron, copper, and various fat-soluble vitamins. In addition, the liver receives about 70% of the blood supply from the intestine through the portal vein, and it also represents the first line of defense against gut-derived antigens (3,5). The gut-liver axis refers to the bidirectional relationship between the gut and its microbiota, and the liver (1). Alcohol intake causes changes in the composition of the intestinal microbiota: it not only causes the drastic reduction population of the beneficial species but also destroys the intestinal barrier, causing toxicity and pathogenic bacteria to enter the liver through the "gut-liver axis", which induces inflammation and causes damage to the liver. In a study conducted among 18-year-old Swedish participants, the relationship between alcohol consumption and liver disease was analyzed. It was found that teenagers who drink more than 30 grams of alcohol per day are 5 to 11 times more likely to develop the severe liver disease (2). Consequently, excessive drinking harms health through the gut-liver axis.</div>   Increased demand for liver health supplements <div style="text-align: justify;">The Centers for Disease Control & Prevention (CDC) reported that, in 2018, liver disease was diagnosed in approximately 4.5 million American adults. Studies suggest that increased consumption of fast food and alcohol contributes to the high prevalence of liver cancer and fatty liver disease (6). Hence, the rising prevalence of liver diseases has increased concerns among consumers about liver health, thereby driving the consumption of supplements. According to Grand View Research, the global liver health supplements market size in 2020 was valued at USD 766.44 million and is expected to reach USD 948.61 million in 2025 (6).</div>   Unlocking the secret from longevity village <div style="text-align: justify;">Research suggests that the intestinal flora can be balanced by supplementing lactic acid bacteria, thereby impacting liver health through the path of the “gut-liver axis”.   “Let food be thy medicine and medicine be thy food” (Hippocrates), embracing this concept, the researchers from Yangzhou University found the solution for liver health from longevity village. Streptococcus thermophilus GRX02 strain which was isolated from koumiss (also signified as kumiss or coomys), a fermented dairy product traditionally made from mare’s milk, in longevity village, Altay in Xinjiang, was scientifically demonstrated that it has antioxidant activity and produce enzyme-shaped antioxidants (SOD), which protects cells from oxidative damage, removes the lipid peroxidation product malondialdehyde (MDA), and reduces liver damage (8).</div> <div style="text-align: justify;">  Synbio Tech Inc. incorporates Streptococcus thermophilus GRX02 in its liver care probiotics formula, SynForU™-HepaAid which contains BAL06, LA27, LPC48, and LRH113 as well. Growing evidences suggest that lactic acid bacteria can protect liver health by regulating the population of gastrointestinal flora and physiological functions. Through the supplementation of lactic acid bacteria, adopting healthy lifestyles not only protect the intestinal health but also maintain good liver functions, and lead a healthy life.</div> Reference:     [1] Albillos, A., De Gottardi, A., & Rescigno, M. (2020). The gut-liver axis in liver disease: pathophysiological basis for therapy. Journal of hepatology, 72(3), 558-577. [2]Avila, M. A., Dufour, J. F., Gerbes, A. L., Zoulim, F., Bataller, R., Burra, P., ... & Thursz, M. R. (2020). Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting. Gut, 69(4), 764-780. [3] Bajaj J. S. (2019). Alcohol, liver disease and the gut microbiota. Nature reviews. Gastroenterology & hepatology, 16(4), 235–246. [4] Chen, C. Y., Huang, H. Y., Tseng, F. Y., Chiu, Y. C., & Chen, W. J. (2017). Media alcohol advertising with drinking behaviors among young adolescents in Taiwan. Drug and alcohol dependence, 177, 145-152. [5] Compare, D., Coccoli, P., Rocco, A., Nardone, O. M., De Maria, S., Cartenì, M., & Nardone, G. (2012). Gut–liver axis: the impact of gut microbiota on non alcoholic fatty liver disease. Nutrition, Metabolism and Cardiovascular Diseases, 22(6), 471-476. [6] Grand View research. (2019, December). Liver Health Supplements Market Size,Share,IndustryReport,2025.https://www.grandviewresearch.com/industry-analysis/liver-health-supplements-market [7] World Health Organization, 2014. Global Status Report on Alcohol and Health 2014.World Health Organization Press; Geneva, Switzerland. [8] Xu, Y., Chen, X., Lu, M., Yang, Z., Huang, Y., Liu, D., ... & Gu, R. (2012). In vitro and in vivo Studies on the Antioxidant Effects of Soymilk Fermented with Streptococcus thermophilus grx02. Food Biotechnology, 26(4), 339-350.       <span style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: 8px; line-height: inherit; font-family: "Microsoft Jhenghei", 微軟正黑體, "Trebuchet MS", Arial, Helvetica, sans-serif; vertical-align: baseline; color: rgb(59, 59, 59);">Disclaimer <div style="text-align: justify;"><span style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: 8px; line-height: inherit; font-family: "Microsoft Jhenghei", 微軟正黑體, "Trebuchet MS", Arial, Helvetica, sans-serif; vertical-align: baseline; color: rgb(59, 59, 59);">The information contained herein is based on data known to SYNBIO TECH by their own research and development work and is, to the best of our knowledge, reliable. This sharing of business-to-business information is intended for the general discussion between food and supplement enterprises only, and is not intended for final consumer. The information is provided at “as is” basis and its use is at the recipient’s sole discretion and risk.  Information and statements herein shall not be construed as licenses to practice, or recommendations to infringe, any patents or other intellectual property rights of SYNBIO TECH or others. SYNBIO TECH hereby expressly disclaims (I) any and all liability in connection with such information, including, but not limited to, any liability relating to the accuracy, completeness, or usefulness of such information, and (II) any and all representations or warranties, express or implied, with respect to such information, or any part thereof, including all representations and warranties of title, non-infringement of copyright or patent rights of others, merchantability, fitness or suitability for any purpose, and warranties arising by law, statute, usage of trade or course of dealing. For more information, please contact: <a href="mailto:service@synbiotech.com.tw" style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: 8px; line-height: inherit; font-family: "Microsoft Jhenghei", 微軟正黑體, "Trebuchet MS", Arial, Helvetica, sans-serif; vertical-align: baseline; text-decoration-line: none; outline: none !important;">service@synbiotech.com.tw</a><span style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: 8px; line-height: inherit; font-family: "Microsoft Jhenghei", 微軟正黑體, "Trebuchet MS", Arial, Helvetica, sans-serif; vertical-align: baseline; color: rgb(59, 59, 59);"> or <a href="http://www.synbiotech.com/" style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: 8px; line-height: inherit; font-family: "Microsoft Jhenghei", 微軟正黑體, "Trebuchet MS", Arial, Helvetica, sans-serif; vertical-align: baseline; text-decoration-line: none; outline: none !important;" target="_blank">www.synbiotech.com</a></div>  生合生物科技有限公司Fri, 20 Aug 2021 00:00:00 GMTWINNING AGAINST ALL ODDShttps://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=04e4aac4-b76d-4eb6-850b-10196100c1dd<img alt="WINNING AGAINST ALL ODDS" src="/ckfinder/userfiles/Images/210727-%E5%A5%A7%E9%81%8BTWK10-EN.jpg" style="width: 100%;" /> Hope, courage, resilience <div style="text-align: justify;">Every four years, the world gets ready for the most iconic sporting event. But, as we all know, unlike any other, the Tokyo 2020 Summer Olympics was postponed due to unprecedented COVID-19 pandemic. While the game was delayed, athletes have shown hope, perseverance, resilience and inspired people around the globe; they stood up for discrimination and inequity (8), empowered the powerless and sent a message of hope (12), and brought the athletes’mental health in spotlights (11). They have shown us that athletic greatness goes beyond showcasing of athletic performance but also of courage, hope and resilience. In addition, the Tokyo Olympics is the brilliant testimony of making things happened in unity. Governments, International Olympic Committee (IOC) and health care heroes have worked tirelessly for the game to be held safely. Coaches, family and friends give unwavering supports to their sport stars. Despite all the atypical challenges, 2020 Olympics has made happened, a year later, on 23rd July 2021. </div> Achieving athletic goal <div style="text-align: justify;">It is undeniable that Olympic athletes can be considered as outliers when it comes to physical fitness. However, their superior level of speed and strength do not make them immune to health issues. Studies suggest that Olympians are not only vulnerable to injury but also prone to illness during the sporting event, for example, during the PyeongChang Olympic Winter Games, 12% of the athletes had reported medical encounter for injury and 9% reported an illness (10). With highly transmittable COVID 19 pandemic (9), athletes can be even more vulnerable to infections. During this unprecedented time, the challenges present to athletes is unique than ever before: such as training through the uncertainties and unknowns (2).</div> <div style="text-align: justify;"> Nutrition is important for not only for the prevention of illness; it is also one the numerous factors contribute to peak athletic performance; it can therefore be said that it is the foundation of athletes'  success. In addition, it is noted by IOC that "the amount, composition and the timing of food intake can profoundly affect sports performance". The benefits of proper nutrition include optimal gains from the training program, enhanced recovery, achievement and maintenance of an ideal body weight, reduced risk of injury and illness, consistency in achieving high level of performances (1). </div> TWK10®: to help athletes achieve their personal best <div style="text-align: justify;">International Society of Sports Nutrition(ISSN) acknowledges the potential effects of probiotics to optimize the health, performance, and recovery of athletes such that intake of specific strains may be beneficial for immune function and may reduce the number of sick days an athlete experiences during training or competition (7).  TWK10®, innovative sports probiotic is designed to help athletes push beyond their limit and break the records. TWK10® unlocks the body's potential starting in the gut with a patented strain of Lactobacillus plantarum, a unique strain isolated from Taiwanese kimchi. Research shows that TWK10® can increase the endurance up to 75%. There is robust science behind TWK10®; the result of numerous scientific publications shows the efficacy and safety of TWK10®. The research documents that TWK10® could increase muscle mass, decrease body fat, improve exercise performance and exert anti-fatigue effects (3, 4, 6). In addition, it is plant-based, clean label and vegan-friendly sports nutrition. Notably, TWK10® being the revolutionary and effective sports nutrition has won sports nutrition of the year award at NutraIngredients-USA 2021 (5), moreover, it has also been recognized as Finalist at sports nutrition of the year award at NutraIngredients- Asia 2021. With TWK10®, athletes may achieve their personal best. </div> Indeed, Tokyo 2020 Olympics  is extremely challenging game for the athletes. However, we believe that despite all the atypical challenges, athletes will excel and bring the medals home.  Reference: <div style="text-align: justify;">[1] Achieving Success in Sports. (n.d.). Sportsoracle. Retrieved July 23, 2021, from https://www.sportsoracle.com/Nutrition/Home/</div> <div>[2] Chang, R. (2021, February 16). How Athletes Are Preparing for the Uncertainties of the Tokyo Olympics.Cntraveler.https://www.cntraveler.com/story/how-athletes-are-preparing-for-the-uncertainties-of-the-tokyo-olympics</div> <div style="text-align: justify;">[3] Chen, Y. M., Liao, C. C., Huang, Y. C., Chen, M. Y., Huang, C. C., Chen, W. C., & Chiu, Y. S. (2020). Proteome and microbiota analysis highlight Lactobacillus plantarum TWK10 supplementation improves energy metabolism and exercise performance in mice. Food science & nutrition, 8(7), 3525-3534. [4] Chen, Y. M., Wei, L., Chiu, Y. S., Hsu, Y. J., Tsai, T. Y., Wang, M. F., & Huang, C. C. (2016). Lactobacillus plantarum TWK10 supplementation improves exercise performance and increases muscle mass in mice. Nutrients, 8(4), 205. [5] Daniells, S. (2021, July 19). The NutraIngredients_USA Awards 2021: And the winners are…Nutraingredients-Usa.https://www.nutraingredients usa.com/Article/2021/04/27/NutraIngredients-USA-Awards-2021-Winners-Revealed [6] Huang, W. C., Lee, M. C., Lee, C. C., Ng, K. S., Hsu, Y. J., Tsai, T. Y., ... & Huang, C. C. (2019). Effect of Lactobacillus plantarum TWK10 on exercise physiological adaptation, performance, and body composition in healthy humans. Nutrients, 11(11), 2836. https://www.sportsoracle.com/Nutrition/Overview/ [7] Jäger, R., Mohr, A. E., Carpenter, K. C., Kerksick, C. M., Purpura, M., Moussa, A., ... & Antonio, J. (2019). International society of sports nutrition position stand: probiotics. Journal of the International Society of Sports Nutrition, 16(1), 1-44. [8] Jiwani, R. (2021, March 1). The History of International Women’s Day and Sport. Olympics.Com.https://olympics.com/en/featured-news/iwd-how-sportswomen-have-effected-change [9] Shereen, M. A., Khan, S., Kazmi, A., Bashir, N., & Siddique, R. (2020). COVID-19 infection: Origin, transmission, and characteristics of human coronaviruses. Journal of advanced research, 24, 91. [10] Soligard, T., Palmer, D., Steffen, K., Lopes, A. D., Grant, M. E., Kim, D., ... & Engebretsen, L. (2019). Sports injury and illness incidence in the PyeongChang 2018 Olympic winter games: a prospective study of 2914 athletes from 92 countries. British journal of sports medicine, 53(17), 1085-1092. [11] Svrluga, B. (2021, June 19). Olympians are crying out about their mental health challenges. We should listen. The Washington Post. https://www.washingtonpost.com/sports/olympics/2021/06/19/olympics-mental-health-simone-manuel/ [12] 29 refugee athletes to send a message of solidarity and hope to the world at the Olympic Games Tokyo 2020. (2021, June 8). Olympics. https://olympics.com/ioc/news/29-refugee-athletes-to-send-a-message-of-solidarity-and-hope-to-the-world-at-the-olympic-games-tokyo-2020</div> <span style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: 8px; line-height: inherit; font-family: "Microsoft Jhenghei", 微軟正黑體, "Trebuchet MS", Arial, Helvetica, sans-serif; vertical-align: baseline; color: rgb(59, 59, 59);">Disclaimer <div style="text-align: justify;"><span style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: 8px; line-height: inherit; font-family: "Microsoft Jhenghei", 微軟正黑體, "Trebuchet MS", Arial, Helvetica, sans-serif; vertical-align: baseline; color: rgb(59, 59, 59);">The information contained herein is based on data known to SYNBIO TECH by their own research and development work and is, to the best of our knowledge, reliable. This sharing of business-to-business information is intended for the general discussion between food and supplement enterprises only, and is not intended for final consumer. The information is provided at “as is” basis and its use is at the recipient’s sole discretion and risk.  Information and statements herein shall not be construed as licenses to practice, or recommendations to infringe, any patents or other intellectual property rights of SYNBIO TECH or others. SYNBIO TECH hereby expressly disclaims (I) any and all liability in connection with such information, including, but not limited to, any liability relating to the accuracy, completeness, or usefulness of such information, and (II) any and all representations or warranties, express or implied, with respect to such information, or any part thereof, including all representations and warranties of title, non-infringement of copyright or patent rights of others, merchantability, fitness or suitability for any purpose, and warranties arising by law, statute, usage of trade or course of dealing. For more information, please contact: <a href="mailto:service@synbiotech.com.tw" style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: 8px; line-height: inherit; font-family: "Microsoft Jhenghei", 微軟正黑體, "Trebuchet MS", Arial, Helvetica, sans-serif; vertical-align: baseline; text-decoration-line: none; outline: none !important;">service@synbiotech.com.tw</a><span style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: 8px; line-height: inherit; font-family: "Microsoft Jhenghei", 微軟正黑體, "Trebuchet MS", Arial, Helvetica, sans-serif; vertical-align: baseline; color: rgb(59, 59, 59);"> or <a href="http://www.synbiotech.com/" style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: 8px; line-height: inherit; font-family: "Microsoft Jhenghei", 微軟正黑體, "Trebuchet MS", Arial, Helvetica, sans-serif; vertical-align: baseline; text-decoration-line: none; outline: none !important;" target="_blank">www.synbiotech.com</a></div>  生合生物科技有限公司Wed, 28 Jul 2021 00:00:00 GMTSYNPACK™：Giving probiotics a protective home！https://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=28d5f1b0-d726-42b2-94b0-dfaf6d013cdeSYNPACK™ is developed with the concept of providing home for probiotics. A happy home is where the needs for security, stability and protection for the family members are satisfied. Likewise, a great packaging protects probiotics from degradation and destabilization of formulas.   SYNPACK™ provides optimized probiotic packaging processes and a controlled production environment to prevent the potential obstacles that affect probiotics’potency and viability. In addition, it also provides integrated professional service from formulation, production to packaging to ensure the optimal viability of the probiotic finished products. <img alt="" src="/ckfinder/userfiles/Images/210628-SYNPACK%e6%87%b6%e4%ba%ba%e5%8c%85%e5%9c%96%e8%a3%bd%e4%bd%9c-EN_01.jpg" style="width: 1200px; height: 1200px;" /> <img alt="" src="/ckfinder/userfiles/Images/210628-SYNPACK%e6%87%b6%e4%ba%ba%e5%8c%85%e5%9c%96%e8%a3%bd%e4%bd%9c-EN_02.jpg" style="width: 1200px; height: 1200px;" /> <img alt="" src="/ckfinder/userfiles/Images/210628-SYNPACK%e6%87%b6%e4%ba%ba%e5%8c%85%e5%9c%96%e8%a3%bd%e4%bd%9c-EN_03.jpg" style="width: 1200px; height: 1200px;" /> <img alt="" src="/ckfinder/userfiles/Images/210628-SYNPACK%e6%87%b6%e4%ba%ba%e5%8c%85%e5%9c%96%e8%a3%bd%e4%bd%9c-EN_04(1).jpg" style="width: 1200px; height: 1200px;" /> <img alt="" src="/ckfinder/userfiles/Images/210628-SYNPACK%e6%87%b6%e4%ba%ba%e5%8c%85%e5%9c%96%e8%a3%bd%e4%bd%9c-EN_05.jpg" style="width: 1200px; height: 1200px;" /> <img alt="" src="/ckfinder/userfiles/Images/210628-SYNPACK%e6%87%b6%e4%ba%ba%e5%8c%85%e5%9c%96%e8%a3%bd%e4%bd%9c-EN_06.jpg" style="width: 1200px; height: 1200px;" /> <span style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: 8px; line-height: inherit; font-family: "Microsoft Jhenghei", 微軟正黑體, "Trebuchet MS", Arial, Helvetica, sans-serif; vertical-align: baseline; color: rgb(59, 59, 59);">Disclaimer <span style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: 8px; line-height: inherit; font-family: "Microsoft Jhenghei", 微軟正黑體, "Trebuchet MS", Arial, Helvetica, sans-serif; vertical-align: baseline; color: rgb(59, 59, 59);">The information contained herein is based on data known to SYNBIO TECH by their own research and development work and is, to the best of our knowledge, reliable. This sharing of business-to-business information is intended for the general discussion between food and supplement enterprises only, and is not intended for final consumer. The information is provided at “as is” basis and its use is at the recipient’s sole discretion and risk.  Information and statements herein shall not be construed as licenses to practice, or recommendations to infringe, any patents or other intellectual property rights of SYNBIO TECH or others. SYNBIO TECH hereby expressly disclaims (I) any and all liability in connection with such information, including, but not limited to, any liability relating to the accuracy, completeness, or usefulness of such information, and (II) any and all representations or warranties, express or implied, with respect to such information, or any part thereof, including all representations and warranties of title, non-infringement of copyright or patent rights of others, merchantability, fitness or suitability for any purpose, and warranties arising by law, statute, usage of trade or course of dealing. For more information, please contact: <a href="mailto:service@synbiotech.com.tw" style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: 8px; line-height: inherit; font-family: "Microsoft Jhenghei", 微軟正黑體, "Trebuchet MS", Arial, Helvetica, sans-serif; vertical-align: baseline; text-decoration-line: none; outline: none !important;">service@synbiotech.com.tw</a><span style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: 8px; line-height: inherit; font-family: "Microsoft Jhenghei", 微軟正黑體, "Trebuchet MS", Arial, Helvetica, sans-serif; vertical-align: baseline; color: rgb(59, 59, 59);"> or <a href="http://www.synbiotech.com/" style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: 8px; line-height: inherit; font-family: "Microsoft Jhenghei", 微軟正黑體, "Trebuchet MS", Arial, Helvetica, sans-serif; vertical-align: baseline; text-decoration-line: none; outline: none !important;" target="_blank">www.synbiotech.com</a>  生合生物科技有限公司Wed, 30 Jun 2021 00:00:00 GMTAB-Kefir | Happy gut happy familyhttps://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=777d41bd-1baf-41c3-ace6-063b78a8a66b<img alt="Happy gut happy family" src="/ckfinder/userfiles/Images/%e4%b8%96%e7%95%8c%e8%85%b8%e9%81%93%e6%97%a5%e5%9c%96ai_%e5%b7%a5%e4%bd%9c%e5%8d%80%e5%9f%9f%201%20%e8%a4%87%e6%9c%ac%202.jpg" style="width: 100%;" /> The global probiotics market was worth nearly $49.4 billion in 2018, and it is estimated to reach $69.3 billion by 2023. The growth of probiotics market is mainly attributed to the growing consumer awareness regarding the health benefits of probiotics, increasing use of probiotics as a dietary supplement, and growing scientific researches on probiotics for new applications. It is reported that increasing number of people take probiotic supplements daily for gut health, weight loss, bloating, indigestion, and other health benefits. Research indicated that the gut microbiota plays a significant role in metabolism and energy utilization. It affects the body’s health from birth and throughout life by controlling food digestion, the immune system, nervous system, and other bodily processes. If gut microbiota has the perturbations or changes in the composition of microbial communities, it may contribute to the development of many diseases [2]. Several studies have demonstrated that probiotics could introduce beneficial functions into the gastrointestinal tract or enhance the functionality of existing microbial communities [3]. The mechanisms of probiotics include manipulation of gut microbiota diversities, immunomodulation, fortification of the intestinal barrier, and stimulation of epithelial cell proliferation. With the rapid growth rate, probiotics and fermented milk products have attracted great attention from the food industry and health care industry  [1]. Kefir, a type of fermentation milk with long history, has been used as an effective agent for the prevention of various health issues such as gastrointestinal diseases and allergies. AB-Kefir is a powdered-kefir product. SYNBIO TECH INC. selected and screened five strains of lactic acid bacteria from kefir and subsequently recombined them with Lactobacillus acidophilus LA1063 and Bifidobacterium longum BL986. The competitive advantage of AB-Kefir over the traditional Kefir is its ability to produce a variety of postbiotics (metabolic byproducts), such as bacteria, vitamin B, organic acids, essential amino acids, and water-soluble polysaccharides, which are involved in the regulation of cell metabolism and energy production. Furthermore, AB-Kefir keeps all the substances active with the coating technology SYNTEK™ thorough. This unique technology improve the quality of probiotic products in terms of strain potency, stability, gastric acid/bile salt tolerance and specific functions. In addition, clinical studies have shown that consuming AB-kefir can alleviate abdominal symptoms, ranging from diarrhea, abdominal pain, and abdominal bloating, also resulted in a considerable improvement of the general well-being [4]. Gastrointestinal problems are prevalent in the society nowadays. Probiotic supplements that confer positive effects on the digestive health and overall well-being have become a worldwide booming market in recent years. Many studies have shown that kefir, with its complex microbial community, exerts beneficial effects on gastrointestinal functions. Additionally, it has also been found to aid in the regulation of the digestive systems of lactose-intolerant individuals. Therefore, based on their beneficial effects and tolerability, AB-Kefir probiotics are highly suitable to maintain the gut health of the whole family from children to seniors. Reference: [1] Frank, D. N., Zhu, W., Sartor, R. B., & Li, E. (2011). Investigating the biological and clinical significance of human dysbioses. Trends in microbiology, 19(9), 427–434. [2] O’Toole, P. W., & Cooney, J. C. (2008). Probiotic bacteria influence the composition and function of the intestinal microbiota. Interdisciplinary perspectives on infectious diseases, 2008, 175285. [3] Pflughoeft, K. J., & Versalovic, J. (2012). Human microbiome in health and disease. Annual review of pathology, 7, 99–122. [4] Wang, M. C., Zaydi, A. I., Lin, W. H., Lin, J. S., Liong, M. T., & Wu, J. J. (2019). Putative probiotic strains isolated from kefir improve gastrointestinal health parameters in adults: A randomized, single-blind, placebo-controlled study. Probiotics Antimicro. Prot. <img alt="AB-Kefir" src="/ckfinder/userfiles/Images/60232309_m.jpg" style="width: 100%;" /> <span style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: 8px; line-height: inherit; font-family: "Microsoft Jhenghei", 微軟正黑體, "Trebuchet MS", Arial, Helvetica, sans-serif; vertical-align: baseline; color: rgb(59, 59, 59);">Disclaimer <span style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: 8px; line-height: inherit; font-family: "Microsoft Jhenghei", 微軟正黑體, "Trebuchet MS", Arial, Helvetica, sans-serif; vertical-align: baseline; color: rgb(59, 59, 59);">The information contained herein is based on data known to SYNBIO TECH by their own research and development work and is, to the best of our knowledge, reliable. This sharing of business-to-business information is intended for the general discussion between food and supplement enterprises only, and is not intended for final consumer. The information is provided at “as is” basis and its use is at the recipient’s sole discretion and risk.  Information and statements herein shall not be construed as licenses to practice, or recommendations to infringe, any patents or other intellectual property rights of SYNBIO TECH or others. SYNBIO TECH hereby expressly disclaims (I) any and all liability in connection with such information, including, but not limited to, any liability relating to the accuracy, completeness, or usefulness of such information, and (II) any and all representations or warranties, express or implied, with respect to such information, or any part thereof, including all representations and warranties of title, non-infringement of copyright or patent rights of others, merchantability, fitness or suitability for any purpose, and warranties arising by law, statute, usage of trade or course of dealing. For more information, please contact: <a href="mailto:service@synbiotech.com.tw" style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: 8px; line-height: inherit; font-family: "Microsoft Jhenghei", 微軟正黑體, "Trebuchet MS", Arial, Helvetica, sans-serif; vertical-align: baseline; text-decoration-line: none; outline: none !important;">service@synbiotech.com.tw</a><span style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: 8px; line-height: inherit; font-family: "Microsoft Jhenghei", 微軟正黑體, "Trebuchet MS", Arial, Helvetica, sans-serif; vertical-align: baseline; color: rgb(59, 59, 59);"> or <a href="http://www.synbiotech.com/" style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: 8px; line-height: inherit; font-family: "Microsoft Jhenghei", 微軟正黑體, "Trebuchet MS", Arial, Helvetica, sans-serif; vertical-align: baseline; text-decoration-line: none; outline: none !important;" target="_blank">www.synbiotech.com</a>  生合生物科技有限公司Thu, 27 May 2021 00:00:00 GMTAnnouncement on COVID-19 Business Operationshttps://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=3fe879b8-a59e-4015-ba7b-a5d2676dfa5c<div style="text-align: right;">Date: 21st May 2021</div>   <div style="text-align: justify;">In response to the challenges and uncertainties of COVID-19, please be informed that SYNBIO TECH. has launched a contingency plan and measures for the purpose of continuously supplying safe, healthy and high-quality probiotics to our global customers.   Our commitment to the employees The health and wellness of our employees is our top priority. Therefore, we have instituted guidelines and measures including monitoring temperature, establishing cleaning and disinfection procedures, restricting business trip, prohibiting customers and suppliers visit, following social distancing guidelines, establishing remote work and providing shift flexibility to ensure employees’ health and productivity.   Our commitment to the continuity of supply chain In accordance with our operational risk policy, we have ensured our stock safety. Furthermore, we have requested the contingency plans and health assessment plan of our suppliers in order to maintain the business continuity and product quality, so that we live up to the commitment towards our customers, at the same time, mitigate the effects of the COVID-19.   Please also be assured, that we are closely monitoring development of the epidemic to ensure that we are taking necessary actions to protect our employees and customers.   Finally, we would like to express our sincere gratitude to the medical workers and epidemic investigators for their daily sacrifice. We hope that the damages done by COVID-19 will be restored soon.</div>   <div style="text-align: right;">Lian Chwan Yang, President</div> 生合生物科技有限公司Fri, 21 May 2021 00:00:00 GMTSynForU™-GastroKeep – Might be key to your Stomachhttps://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=50c33f7a-57e6-41d3-bf87-377b28e4461e<img alt="SynForU™-GastroKeep – Might be key to your Stomach" src="/ckfinder/userfiles/Images/97805996_m.jpg" style="width: 100%;" /> “People with an upset stomach may benefit from probiotics to being well, suggest results from animal and human study from SYNBIO TECH.”   The upset stomach, like gastric ulcers or abdominal bloating, are fairly common. The majority of people with gastric ulcers do not experience any symptoms, but some may experience pain, diarrhea, or bloating. One of the most common pathogenic bacteria is Helicobacter pylori (H. pylori) which can lead to stomach inflammation, gastritis ulcers, and even stomach cancer if left untreated. Therefore, gastrointestinal healthcare is necessary.   The most common treatment of upset stomach infections with H. pylori is using multiple rounds of antibiotics, but there are many side effects and the risk of bacterial resistance may be increasing. To Completely eliminate H. pylori management strategies, effective dietaries and probiotics supplementation are gaining favor. The nutrition of balance dietaries and probiotics can maintain the good microbiota in our guts.    In addition to the research of prescription medications, studies on the mechanism between probiotic and H. pylori have been published since 2000. The result indicated that the probiotics have a suppressing effect on H. pylori of in vitro experiments as well as human studies (3).   The confirmed inhibitory mechanism of probiotics against H. pylori as below (2): <ul> <li>Probiotics can aggregate with H. pylori and compete the nutrition resource in stomach.</li> <li>Probiotics inhibit H. pylori growth by secreting short chain fatty acids and antibacterial substances.</li> <li>The probiotics can integrate with H. pylori and discharge through the effect of aggregation. </li> </ul> According to the Taiwan invention patent prospectus, L. helveticus LA27, L. pentosus LPS16 and L. plantarum LP27 could successfully inhibit H. pylori growth through the live bacteria and metabolites (1). Due to the production of antimicrobial substances competing with H. pylori for adhesion receptors, probiotics could stimulate mucin production and stabilize the stomach mucosal barrier (4). With taking the blend formula probiotics (LA27. LP23 and LPS16) for two months, the number of H. pylori in stomach decreased significantly in animal and human study (5). While it cannot be viewed as an alternative to antibiotics, taking probiotics daily could still be considered as an effective complementary strategy to help manage H. pylori infection. Total Stomach Probiotic solution - SynForU-GastroKeep - can help reduce risk of H. pylori infections and protect the gut health.   Reference: [1] 林金生、李幸芬、吳俊忠、鄭伯忻（2013）。中華名國發明專利號I392498。台北：經濟部智慧財產局。 [2] Goderska, K., Agudo Pena, S., & Alarcon, T. (2018). Helicobacter pylori treatment: antibiotics or probiotics. Applied microbiology and biotechnology, 102(1), 1–7. [3] Kim MN, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, Lee DH, Kim JS, Jung HC, Song IS. The effects of probiotics on PPI-triple therapy for Helicobacter pylori eradication. Helicobacter. 2008;13(4):261–268. [4] Zhang, C., Zhang, H., Yu, L., & Cao, Y. (2014). Helicobacter pylori dwelling on the apical surface of gastrointestinal epithelium damages the mucosal barrier through direct contact. Helicobacter, 19(5), 330–342. [5] Zheng, P. X., Fang, H. Y., Yang, H. B., Tien, N. Y., Wang, M. C., & Wu, J. J. (2016). Lactobacillus pentosus strain LPS16 produces lactic acid, inhibiting multidrug-resistant Helicobacter pylori. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 49(2), 168–174. https://doi.org/10.1016/j.jmii.2014.04.014 Disclaimer The information contained herein is based on data known to SYNBIO TECH by their own research and development work and is, to the best of our knowledge, reliable. This sharing of business-to-business information is intended for the general discussion between food and supplement enterprises only, and is not intended for final consumer. The information is provided at “as is” basis and its use is at the recipient’s sole discretion and risk.  Information and statements herein shall not be construed as licenses to practice, or recommendations to infringe, any patents or other intellectual property rights of SYNBIO TECH or others. SYNBIO TECH hereby expressly disclaims (I) any and all liability in connection with such information, including, but not limited to, any liability relating to the accuracy, completeness, or usefulness of such information, and (II) any and all representations or warranties, express or implied, with respect to such information, or any part thereof, including all representations and warranties of title, non-infringement of copyright or patent rights of others, merchantability, fitness or suitability for any purpose, and warranties arising by law, statute, usage of trade or course of dealing. For more information, please contact: <a href="mailto:service@synbiotech.com.tw" style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: 8px; line-height: inherit; font-family: "Microsoft Jhenghei", 微軟正黑體, "Trebuchet MS", Arial, Helvetica, sans-serif; vertical-align: baseline; text-decoration-line: none; outline: none !important;">service@synbiotech.com.tw</a> or <a href="http://www.synbiotech.com/" style="margin: 0px; padding: 0px; box-sizing: border-box; border: 0px; font-variant-numeric: inherit; font-variant-east-asian: inherit; font-stretch: inherit; font-size: 8px; line-height: inherit; font-family: "Microsoft Jhenghei", 微軟正黑體, "Trebuchet MS", Arial, Helvetica, sans-serif; vertical-align: baseline; text-decoration-line: none; outline: none !important;" target="_blank">www.synbiotech.com</a>  生合生物科技有限公司Mon, 26 Apr 2021 00:00:00 GMTLet your gut talk to your brain.https://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=2bc438cf-1501-4163-82aa-7b4f6744947e<img alt="Let your gut talk to your brain." src="/ckfinder/userfiles/Images/%E8%85%A6%E5%9C%96.jpg" style="width: 100%;" /> May stress affect the brain? Because of the high developing speed of the world, stress becomes an inevitable part in our normal life. In fact, 2 out of 3 adults report experiencing some level of stress in their everyday lives and over 1 out of 3 teenagers need to face fierce competence with great stress. With lots of stress may seriously affect our physical and mental well-being, it would cause negative effects of our immune system and the brain ability. Moreover, it may inhibit the ability to form memories and loss part of the cognitive ability. In order to maintain a healthy state and a clear mind, the properly relaxation and stable guts microbiota are the keys point.   The second brain – Your gut. The intestines are often referred to as our body’s second brain because there are hundreds of billion neurons connecting the brain to the intestines and secreting various hormones or neurotransmitter. Many studies have shown that the gut-brain connection is bidirectional and the routes of communication between the microbiota and brain are slowly being unraveled. The imbalance gut microbiota can cause immune system problems, mental perturbations and endocrine unbalance through different pathways such as the autonomic, enteric nervous system and the endocrine system (1). That is the brain communicating with the intestines microbiota, or more scientifically known as the Gut-Brain Axis Source.   New research and future trends of probiotics. Through the Gut-Brain Axis, your guts microbiota can also talk to your brain. Recent researches show that consuming probiotics may help improve your immune system and the brain health. The animal experimentation published in Translational Psychiatry from Xiao et al. (2020) indicates that the group with a multi-strain probiotics blend (BL986, LA1063, LF26, LH43, LPC12, LRH10, ST30) shows the gut microbiota composition was reshaped and the richness was significantly increased. Moreover, it shows a decrease concentration of inflammatory cytokines and the upregulate of intestinal protein expression (3). Ni et al. (2019) found that Lactobacillus casei LC122 and Bifidobacterium longum BL986 can also balance the gut microbiota, upregulation of neurodegenerative, and neurotrophic factors expressions which can promote the cognition of mice in the animal model (2). Consequently, with probiotics supplement can not only regulate the gut microbiota but also maintain the healthy state of brain.   A healthier gut, a healthier brain. Probiotics are the top seller in the U.S. mainstream and natural supplement market, racking up sales of $759 million and $126.9 million, respectively, last year based on SPINS report on the 52 weeks ending November 29, 2020. Over the past years, there has been substantial research in the field of probiotics which specifically into the different mechanism of probiotic action within the host. The most important thing is that the probiotics category will continue to grow and infiltrate multiple product categories in a variety of delivery formats to satisfy the needs of a large cross-section of consumers, providing options for everyone. Probiotics could cause positive effect on a clear and active mind by maintaining the gut microbiota with the Gut-Brain Axis. Supplementation of probiotics continuously may not only support a healthier gut, but a healthier brain.   Reference: [1] Morais, L. H., Schreiber, H. L., 4th, & Mazmanian, S. K. (2020). The gut microbiota-brain axis in behaviour and brain disorders. Nature reviews. Microbiology, 10.1038/s41579-020-00460-0. Advance online publication. [2] Ni Y, Yang X, Zheng L, et al. Lactobacillus and Bifidobacterium Improves Physiological Function and Cognitive Ability in Aged Mice by the Regulation of Gut Microbiota. Mol Nutr Food Res. 2019;63(22): e1900603. [3] Xiao, J., Wang, T., Xu, Y., Gu, X., Li, D., Niu, K., Wang, T., Zhao, J., Zhou, R., & Wang, H. L. (2020). Long-term probiotic intervention mitigates memory dysfunction through a novel H3K27me3-based mechanism in lead-exposed rats. Translational psychiatry, 10(1), 25. Disclaimer The information contained herein is based on data known to SYNBIO TECH by their own research and development work and is, to the best of our knowledge, reliable. This sharing of business-to-business information is intended for the general discussion between food and supplement enterprises only, and is not intended for final consumer. The information is provided at “as is” basis and its use is at the recipient’s sole discretion and risk.  Information and statements herein shall not be construed as licenses to practice, or recommendations to infringe, any patents or other intellectual property rights of SYNBIO TECH or others. SYNBIO TECH hereby expressly disclaims (I) any and all liability in connection with such information, including, but not limited to, any liability relating to the accuracy, completeness, or usefulness of such information, and (II) any and all representations or warranties, express or implied, with respect to such information, or any part thereof, including all representations and warranties of title, non-infringement of copyright or patent rights of others, merchantability, fitness or suitability for any purpose, and warranties arising by law, statute, usage of trade or course of dealing. For more information, please contact: <a href="mailto:service@synbiotech.com.tw">service@synbiotech.com.tw</a> or <a href="http://www.synbiotech.com" target="_blank">www.synbiotech.com</a>  生合生物科技有限公司Fri, 26 Mar 2021 00:00:00 GMTThe patented probiotics solution for women's health.https://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=6494a116-bd11-41dd-886b-930d083ce5fd<img alt="" src="/ckfinder/userfiles/Images/48105417_s.jpg" style="width: 100%;" /> Vaginal infections are a common problem in women According to the report of World Health Organization (WHO), having a cold is not the most common problem to bothering women. The vaginal and urinary tract infections are bothering women for a long time. Moreover, the percentage of getting the urinary tract infection of women is eight times as high as men. There are one billion women worldwide troubled by the vaginal and urinary tract infection. Among the statistics data, nearly 90% of women over 30 years-old have been diagnosed with those infections, and over 60% of women have to cost 2-3 days for treating the vaginal or urinary tract infection every month. (3)   The healthy biomarker of vagina –LACTOBACILLI. While the gut microbiome has recently gotten a lot of attention, the vaginal microbiome also plays a powerful role in women's health. The vagina is host to hordes of bacteria and some yeast, and women are probably most aware of them when an overgrowth of the wrong ones causes annoying symptoms. The primary bacteria of a healthy individual are of the genus Lactobacillus and the lactic acid they produce is thought to protect against infection by pathogenic species. Researchers note that the genus Lactobacilli has a notable ability to stick to the walls of the vagina, which can make it particularly helpful in restoring the balance of microorganisms in this part of the body. Furthermore, Lactobacilli make the vagina acidic, which is important in helping to prevent a condition known as bacterial vaginosis.(2)   Probiotics care of women. The healthy state of women would affect the vagina microbiota. When women have a hormonal imbalance, the vagina microbiota might lose the balance and get the infection. According to the research, consuming lactobacilli bacteria might prevent the overgrowth of harmful organisms that cause infection. Further, a study found that daily consumption of an oral probiotic containing lactobacilli bacteria can reduce bad bacteria and yeast in the vagina. The R&D group of SYNBIO TECH has found that the complex probiotic formula (LA25、LDL114、LP115、LF26、LRH10、LPC12) would produce lactic acid and hydrogen peroxide which could be auto inhibitory or be toxic to adjacent bacteria, fungi or viruses. Also, the probiotics in the vagina would compete with pathogenic microorganisms in binding sites and nutrition in the vaginal epithelium microenvironment, and inhibit the adherence and overgrowth of pathogens.(1)   Supplementation of probiotics continuously will be a good way maintaining the normal flora and keeping healthy vaginal and urinary tract. In addition to supplementing of probiotics, following a balanced, nutrient-dense diet, getting enough physical activity, managing underlying health conditions, reducing stress, and getting plenty of rest are all essential for your overall health and staying away from kind of infections. Reference: [1]張憶如，李幸芬，朱明財，林金生。2013。抑制陰道炎病原菌之乳酸桿菌及其用途。中華民國發明專利號I 412371 。 [2]Amabebe, E., & Anumba, D. (2018). The Vaginal Microenvironment: The Physiologic Role of Lactobacilli. Frontiers in medicine, 5, 181. [3]Reid G, Bruce AW. Urogenital infections in women: can probiotics help?. Postgrad Med J. 2003;79(934):428-432. Disclaimer The information contained herein is based on data known to SYNBIO TECH by their own research and development work and is, to the best of our knowledge, reliable. This sharing of business-to-business information is intended for the general discussion between food and supplement enterprises only, and is not intended for final consumer. The information is provided at “as is” basis and its use is at the recipient’s sole discretion and risk.  Information and statements herein shall not be construed as licenses to practice, or recommendations to infringe, any patents or other intellectual property rights of SYNBIO TECH or others. SYNBIO TECH hereby expressly disclaims (I) any and all liability in connection with such information, including, but not limited to, any liability relating to the accuracy, completeness, or usefulness of such information, and (II) any and all representations or warranties, express or implied, with respect to such information, or any part thereof, including all representations and warranties of title, non-infringement of copyright or patent rights of others, merchantability, fitness or suitability for any purpose, and warranties arising by law, statute, usage of trade or course of dealing. For more information, please contact: <a href="mailto:service@synbiotech.com.tw">service@synbiotech.com.tw</a> or <a href="http://www.synbiotech.com">www.synbiotech.com</a>  生合生物科技有限公司Thu, 25 Feb 2021 00:00:00 GMTSYNPACK™ - Better probiotics, pack to homehttps://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=4c56f7db-15b8-4123-9fce-72e6780c1735<img alt="SYNPACK- Culture Optimization of Package Technologies" src="/ckfinder/userfiles/Images/210127-%e9%9b%bb%e5%ad%90%e5%a0%b1%e5%9c%96%e8%a3%bd%e4%bd%9c-SYNPACK-%e8%8b%b1_%e5%b7%a5%e4%bd%9c%e5%8d%80%e5%9f%9f%201.jpg" style="width: 100%;" /> The outbreak of COVID-19 and its impact have raised consumer’s awareness of individual health and well-being. Awareness of the need to build immunity is leading to greater focus on nutrition, especially probiotics dietary supplement. Therefore, more and more importance has been attached to the quality of probiotics. A variety of factors, which include strain identity, fermentation technique, product formula, packaging and storage condition, would affect the quality and effective of probiotic products. As viability is key, at sufficient amounts and until end of shelf life, probiotics need to be manufactured in such a way that they are robust and stable. They also need to be included in consumer products that allow their survival, in sufficient numbers, until end of shelf-life. Sufficient levels of the probiotic strains must be contained in the final product throughout the shelf life in order to be able to deliver the claimed health benefit. Consequently, the amount of viable bacteria at end of shelf-life is the basic standard for probiotic products as well as the stability and survival rate are the key of product quality. Water activity, temperature and oxygen are the three factors influencing the stability of probiotic products. When the probiotics were exposed to air, high temperature and high humidity, the stability and the number of viable bacteria would decrease. Therefore, how to control all the steps of the production process and ensure ideal conditions for stability are the tall order of probiotic industry. SYNBIO TECH INC. is a leading biotechnology company specializing in research and manufacture on probiotics and their applications. Our professional R&D team and skillful production technology can efficiently provide customized ODM/OEM service and every possible product application to help customers to deal with the large scale of market demand and the new products development. With our efforts, we launch our new package technique—SYNPACK™.  SYNPACK™ is an integrated professional service. 1. Team Up – Max formula.     Combination of big data, ingredient know-how and nutrition knowledge provides maximum function, best stability and optimum quality for your probiotic product.   2. Level Up – Best package. Upgrade the packing technology includes improving filling techniques, enhancing gas composition control, selecting packing material, we have the best-preserved package for your best-selling the probiotic product. 3. Step Up – Most guarantee. Holistic production process control with 68 control points ensures your CFU by the end of shelf-life. We care about what consumers sees and what consumer takes in both quality and in numbers.to the expiration date.  SYNPACK ™ is our core technology for serving customers to design finished probiotic products and provide a comfort home for probiotics. With a wealth of experience in the ODM service of probiotic products and a number of international quality certificates, we control and monitor every key points affected on the stability of probiotics products from raw materials, formulation, and packaging. As a result, SYNPACK™ has the uniqueness to enhance the stability of probiotics products in capsule and sachet forms to provide customer high quality, effective, safe, stable competitive probiotics products.  生合生物科技有限公司Wed, 27 Jan 2021 00:00:00 GMTSynForU™-ImmuUp Boost better immune system through gut microbiomehttps://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=1e8bd4db-a46f-4bfb-b4ce-efb69fa94edf<img alt="" src="/ckfinder/userfiles/Images/30321698_L.jpg" style="width: 100%;" /> The winter holidays are upon us. But this year, 2020, the pandemic has made everyone gathering more difficult. Almost one year into the pandemic, Covid-19 has claimed more than 1.7 million people and infected 80 million people worldwide. During the pandemic, maintaining and boosting health is top of mind for many people. Numerous steps such as handwashing and regular exercising can keep people away from the virus. One of the best defenses is to maintain a healthy immune system(3)。 How to strengthen your immune system this winter? ▲To maintain an exercise routine. ▲To deal with sleep deprivation. ▲To eat balance diet with sufficient nutrients. Moreover, research has shown that the gut microbiome plays an essential role in the human immune response to infection and in maintaining health (1). A healthy gut microbiome can help to prevent potentially dangerous immune over-reactions. People can also support gut microbiome by regularly eating natural food and nutritional supplements, which contain rich vitamins and live microbes-probiotics. Furthermore, the interactions between probiotics and immunity are increasingly well understood(2)。 SynbioTech selected and developed an excellent formula SynForU™-ImmuUp to help in boosting our immune system, which contains patented strain Lactobacillus plantarum LP28 and Lactobacillus rhamnosus LRH113. LP28 is a plant-derived lactic acid bacterium screened from Daxi dried bean curd in Taiwan which has excellent properties in gastric acid and bile tolerance because of growing in the extreme environment. SynForU™-ImmuUp is the perfect formula which can maintain the gut microbiome and supports your immune system. Overall, the human immune system is an important line of defense against the invasion of pathogens. Maintaining a balanced diet, getting enough sleep, engaging in regular exercise, and supplementing with probiotics are some of the most important ways to help keep immune system healthy and reduce the probability of infection and illness. Reference: [1] Dalessandri, T., & Strid, J. (2014). Beneficial autoimmunity at body surfaces - immune surveillance and rapid type 2 immunity regulate tissue homeostasis and cancer. Frontiers in immunology, 5, 347. [2] Fung, T. C., Olson, C. A., & Hsiao, E. Y. (2017). Interactions between the microbiota, immune and nervous systems in health and disease. Nature neuroscience, 20(2), 145–155. [3] Lomax, A. R., & Calder, P. C. (2009). Probiotics, immune function, infection and inflammation: a review of the evidence from studies conducted in humans. Current pharmaceutical design, 15(13), 1428–1518. [4] Toscano, M., De Grandi, R., Stronati, L., De Vecchi, E., & Drago, L. (2017). Effect of Lactobacillus rhamnosus HN001 and Bifidobacterium longum BB536 on the healthy gut microbiota composition at phyla and species level: A preliminary study. World journal of gastroenterology, 23(15), 2696–2704. [5] Yousfi, N., Bragazzi, N. L., Briki, W., Zmijewski, P., & Chamari, K. (2020). The COVID-19 pandemic: how to maintain a healthy immune system during the lockdown - a multidisciplinary approach with special focus on athletes. Biology of sport, 37(3), 211–216.  生合生物科技有限公司Mon, 28 Dec 2020 00:00:00 GMTGABA | Naturally ease your nervous system. https://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=4889e63f-cbba-46ea-a3e7-d6f9d9d4695e<img alt="GABA | Naturally ease your nervous system. " src="/ckfinder/userfiles/Images/10787033_L.jpg" style="width: 100%;" /> Job insecurity during the COVID-19 pandemic has led to a significant mental health burden among young adults, according to market survey results. These factors are likely to affect sleep patterns, a phenomenon that may have serious downstream impacts on physical and mental health. When people have trouble sleeping, they may take sleeping pills, medication or alcohol. However, substance misuse or withdrawal from drugs can cause sleep problems or make them worse. Therefore, nutritional supplements with γ-aminobutyric acid (GABA) may prevent people from attraction of medication and alcohol.   γ-aminobutyric acid (GABA) is an amino acid produced naturally in the brain. GABA functions as a neurotransmitter, facilitating communication among brain cells. It can reduce the activity of neurons in the brain and central nervous system, which in turn has a broad range of effects on the body and mind, including increased relaxation, reduced stress, balanced mood, alleviation of pain, and a boost to sleep.   Nowadays, there are three production methods of GABA, which are chemical synthesis, biological extraction and microbial fermentation. 1. Chemical synthesis With high temperature reaction, phthalimide potassium salt and γ-chlorobutyronitrile can synthesis GABA. However, GABA produced from this method cannot be made into food due to the chemical solvent residues. 2. Biological extraction With enzyme reaction, varieties grains can be made into GABA. This method can only have few production and it results in a higher cost. 3. Microbial fermentation Most of the nutritional supplements market through a fermentation process using lactic acid bacteria to produce GABA. With generally recognized as safe lactic acid bacteria, it can have high production.   Synbio-GABA is produced by natural fermentation technology with a unique lactic acid bacterial strain, which has better bioavailability and safety than GABA made by chemical synthesis. It is natural, healthy, and effective. Due to the COVID-19, the nutritional supplements market of GABA is expected to grow exponentially. GABA, a natural stress reliever, can be a nutritional supplement to induce relaxation, but also can combine with probiotics to maintain gut microbiota. Reference: [1] Jiang, J. G., Huang, X. J., Chen, J., & Lin, Q. S. (2007). Comparison of the sedative and hypnotic effects of flavonoids, saponins, and polysaccharides extracted from Semen Ziziphus jujube. Natural Product Research,21(4), 310-320. [2] Franco, L., Sánchez, C., Bravo, R., Rodríguez, A. B., Barriga, C., Romero, E., & Cubero, J. (2012). The sedative effect of non-alcoholic beer in healthy female nurses. PloS one, 7(7), e37290. [3] Abdou, A. M., Higashiguchi, S., Horie, K., Kim, M., Hatta, H., & Yokogoshi, H. (2006). Relaxation and immunity enhancement effects of gamma-aminobutyric acid (GABA) administration in humans. BioFactors (Oxford, England), 26(3), 201–208. [4] Yoto, A., Murao, S., Motoki, M., Yokoyama, Y., Horie, N., Takeshima, K., Masuda, K., Kim, M., & Yokogoshi, H. (2012). Oral intake of γ-aminobutyric acid affects mood and activities of central nervous system during stressed condition induced by mental tasks. Amino acids, 43(3), 1331–1337.  生合生物科技有限公司Wed, 25 Nov 2020 00:00:00 GMTSYNBIO TECH INC. successfully passed the FSSC 22000 certification audit!https://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=477245e1-5247-43f7-a1e8-0bdb5b55e9dc<img alt="SYNBIO TECH INC. successfully passed the FSSC 22000 certification audit!" src="/ckfinder/userfiles/Images/company%20FSSC22000(1).jpg" style="width: 100%;" /> SYNBIO TECH INC. is a leading probiotic manufacturer specializing in research on probiotics and their applications. We believe that probiotics, obtained from nature, are the best gifts bestowed upon humankind. Therefore, we are committed to studying the application of lactic acid bacteria in various fields. As a leading brand in the research and production of lactic acid bacteria in Taiwan, SYNBIO TECH INC. holds the spirit of “Better Probiotics, Better Life.” It has been engraved into the company's philosophy to continuously provide the best solutions for our probiotics. Only by providing high-quality products can we obtain the affirmation and trust of customers.   The FSSC2000 certificate is a proud step for us in the direction of the high-level excellence we strive to achieve every day. We hold food safety and quality in the highest esteem so that we can continue to provide products that support the improvement of health and wellbeing worldwide.   FSSC 22000 (Food Safety System Certification) is an internationally accepted certification scheme based on a combination of ISO 22000 sector specific PRP and FSSC additional requirements. FSSC 22000 has been developed in respond to customer demands for a recognizable standard against which a food safety management system can be audited and certified. The main difference between the two certifications is that the FSSC 22000 scheme, in contrast to the ISO standard, is recognized by the GFSI (Global Food Safety Initiative). GFSI recognition demonstrates that the scheme meets the highest standards globally leading to international food industry acceptance.   To obtain various certifications is only our basic requirement for product quality. We always make effort to upgrade the international quality certifications with high standards of quality regulations! We hold the brand appeal “Caring for human. Caring for earth. Caring for future.’’ We have devoted ourselves to the collection of probiotics from every possible source and study of their functions and possible applications. This allows us to continuously provide recommendations for better human health, animal health, and environmental preservation.   SYNBIO TECH INC. is an enterprise which is keeping learning, creating, and never satisfied. Our innovation and success will make us become the pioneer of this field.  生合生物科技有限公司Wed, 25 Nov 2020 00:00:00 GMTThe Power of Probiotics. The power for You.https://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=97001488-0569-45d1-b608-f96eb591e7cf Recent research found that there is a correlation between the gut microbiota and skeletal muscles which would affect exercise performance and energy metabolism. Therefore, probiotic supplement can not only maintain the composition of gut microbiota but also improve exercise performance. With the raising awareness of health in recent years, more and more people maintain physiological function and overall health through physical activity and fitness. General public are also becoming increasingly aware of the importance of consuming sufficient nutrients, thereby driving the demand for sports nutrition products. Moreover, shifting demographic base in the market from core athletes who regularly consume sports nutrition products to lifestyle users and recreational users focusing on adopting a healthier lifestyle, is expected to create market growth opportunities globally. According to the Allied Market Research report, the sport nutrition market in Asia-Pacific region has been growing in the past five years. The total market is expected to garner $7.8 billion by 2020, and is expected to garner $44 billion by 2021. Asia-Pacific is expected to witness the fastest growth, owing to the increase in demand from countries such as India and China.   Sport with You- Lactobacillus plantarum TWK10™ In previous animal study, results showed group with supplementation of Lactobacillus plantarum TWK10™ could regulate gut microbiota and increase the abundance of helpful bacteria. It could also increase the utilization efficiency of energy through triglycerides was broken down by hydrolysis into fatty acids and significantly increase the number of type I muscle fibers which contribute to the sport performance, such as jogging and cycling. Besides, a total of 54 adults without professional athletic training were enrolled and randomly allocated to the placebo and dose group. Results indicated that supplementation with TWK10™ helped protect against fatigue during athletic activity by decreasing plasma lactate, ammonia, creatine kinase and serum glucose levels, thereby enhancing exercise performance. Based on the results of animal experiments and two clinical human trials, six weeks of supplementation with TWK10™ can significantly improve the endurance and delay exhaustion in exercise performance. <img alt="" src="/ckfinder/userfiles/Images/201023-%E9%9B%BB%E5%AD%90%E5%A0%B1%E5%9C%96%E8%A3%BD%E4%BD%9C-TWK10%E7%94%A2%E5%93%81-%E8%8B%B1_%E5%B7%A5%E4%BD%9C%E5%8D%80%E5%9F%9F%201.jpg" style="width: 100%;" /> A New Option for Your Sport Nutrition - Lactobacillus plantarum TWK10™ Sports nutrition has become a booming market worldwide in recent years due to lifestyle changes. There are variety sports nutrition products in the market every year. Consumers Increasingly aware of the nutritional value of what they get, consumers are demanding healthier and more nutritious supplements. Compare with other sports nutrition products, TWK10™ is a brand new kind product. It can be made in kinds of products type, such as powder and capsule. Also, it can be combined with kinds of nutrition elements, such as whey protein and essential amino acid BCAA.   During the product development, TWK10™ is made with natural elements. Hence, without major allergens, TWK10™ is a gluten-free, lactose-free, and non-genetically product. It is in the line with clean-label product. Moreover, TWK10™ achieved US Self-affirmed GRAS on 2020.   TWK10™ is a functional, competitiveness and novelty product. With efficacies of regulation on gut microbiota and sport performance, TWK10™ is a new option for the sports nutrition market. <img alt="" src="/ckfinder/userfiles/Images/201023-%E9%9B%BB%E5%AD%90%E5%A0%B1%E5%9C%96%E8%A3%BD%E4%BD%9C-TWK10%E6%87%89%E7%94%A8%E7%94%A2%E5%93%81_%E5%B7%A5%E4%BD%9C%E5%8D%80%E5%9F%9F%201.jpg" style="width: 100%;" /> Reference: [1] Barton, W., Penney, N. C., Cronin, O., Garcia-Perez, I., Molloy, M. G., Holmes, E., Shanahan, F., Cotter, P. D., and O'Sullivan, O. (2018). The microbiome of professional athletes differs from that of more sedentary subjects in composition and particularly at the functional metabolic level. Gut, 67(4), 625–633. [2] Chen, Y. M., Wei, L., Chiu, Y. S., Hsu, Y. J., Tsai, T. Y., Wang, M. F., and Huang, C. C. (2016). Lactobacillus plantarum TWK10 Supplementation Improves Exercise Performance and Increases Muscle Mass in Mice. Nutrients, 8(4), 205. [3] Huang, W. C., Chen, Y. H., Chuang, H. L., Chiu, C. C., & Huang, C. C. (2019). Investigation of the Effects of Microbiota on Exercise Physiological Adaption, Performance, and Energy Utilization Using a Gnotobiotic Animal Model. Frontiers in microbiology, 10, 1906. [4] Huang, W. C., Hsu, Y. J., Li, H., Kan, N. W., Chen, Y. M., Lin, J. S., Hsu, T. K., Tsai, T. Y., Chiu, Y. S., and Huang, C. C. (2018). Effect of Lactobacillus Plantarum TWK10 on Improving Endurance Performance in Humans. The Chinese journal of physiology, 61(3), 163–170. [5] Huang, W. C., Lee, M. C., Lee, C. C., Ng, K. S., Hsu, Y. J., Tsai, T. Y., Young, S. L., Lin, J. S., and Huang, C. C. (2019). Effect of Lactobacillus plantarum TWK10 on Exercise Physiological Adaptation, Performance, and Body Composition in Healthy Humans. Nutrients, 11(11), 2836. [6] Okamoto, T., Morino, K., Ugi, S., Nakagawa, F., Lemecha, M., Ida, S., Ohashi, N., Sato, D., Fujita, Y., and Maegawa, H. (2019). Microbiome potentiates endurance exercise through intestinal acetate production. American journal of physiology. Endocrinology and metabolism, 316(5), E956–E966.  生合生物科技有限公司Mon, 26 Oct 2020 00:00:00 GMTHeavy metals make you worry. Probiotics make you healthy.https://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=aac36a15-4bbb-4260-b3fd-a506ca00ce05<img alt="憂心重金屬安心益生菌" src="/ckfinder/userfiles/Images/28132130_m.jpg" style="width: 100%;" /> Along with the rapid development of industry and economy, the pollution of heavy metals is getting worse. Not only is the food we eat polluted, but the air pollution, drinking water and the poor-quality tableware may increase risks of heavy metal exposure. Heavy metals are natural components of the Earth's crust, so they cannot be degraded or destroyed. To a small extent, they enter our bodies via food, drinking water and air. As trace elements, some heavy metals (e.g. copper, selenium, zinc) are essential to maintain the metabolism of the human body. Prolonged exposure to heavy metals such as cadmium, copper, lead, nickel, and zinc can cause deleterious health effects in humans. Hence, how to decrease the lead exposure in daily life is very important.   In Taiwan, most people like to use Chinese medicine for health care and medicinal cuisine and most of the them depend on import. The Chinese medicinal materials market extends all over the country so that the source is not easy to control. Multiple factors would affect the quality of the Chinese medicine such as the climate, place of origin or manufacturing process. Indeed, Chinese medicines generally may contain toxic contaminants, for example, heavy metals, pesticides and aflatoxins residue which make all consumers worry. Notably, cadmium (Cd), lead (Pb), mercury (Hg), and arsenic (As) are classified as strong carcinogens by the International Agency for Research on Cancer. Those heavy metals which accumulating in the body for a long time may cause harmful effects on hepatic, renal, and cerebral tissues or on neurological and hematological functions.   In recent years, studies have found that heavy metals would cause brain, nerve and liver damage even if we absorb a little concentration of them through diet. Moreover, the damage of brain and nerve would easily cause disease and loss of cognitive ability. Heavy metals has been approved to change  gut microbiota composition and break the intestinal mucosal barrier which may be a vital mediator of heavy metals bioavailability and toxicity. However, probiotics have been shown to reduce the absorption of heavy metals in the intestinal tract via the enhancement of intestinal heavy metal sequestration, detoxification of heavy metals in the gut, changing the expression of metal transporter proteins, and maintaining the gut barrier function.   The animal experiment published in Translational Psychiatry from Xiao et al. (2020) indicates that perturbations of the gut microbiota by lead poisoning can thus affect metabolic and physiological functions, thereby contributing to the development or progression of various diseases and nervous system damage in host. In this experiment, the group with a multi-strain probiotics blend (BL986, LA1063, LF26, LH43, LPC12, LRH10, ST30) shows the gut microbiota composition was reshaped and the richness was significantly increased. Therefore, the side effects caused by lead poisoning have been improved. Ni et al. (2019) found that Lactobacillus LC122 and Bifidobacterium longum BL986 can also balance the gut microbiota and make the brain work stably. Consequently, probiotics can reduce the harm of heavy metals and maintain healthy state. Reference: [1] Chi, L., Bian, X., Gao, B., Tu, P., Ru, H., & Lu, K. (2017). The Effects of an Environmentally Relevant Level of Arsenic on the Gut Microbiome and Its Functional Metagenome. Toxicological sciences: an official journal of the Society of Toxicology, 160(2), 193–204. [2] Lu, K., Abo, R. P., Schlieper, K. A., Graffam, M. E., Levine, S., Wishnok, J. S., Swenberg, J. A., Tannenbaum, S. R., & Fox, J. G. (2014). Arsenic exposure perturbs the gut microbiome and its metabolic profile in mice: an integrated metagenomics and metabolomics analysis. Environmental health perspectives, 122(3), 284–291. [3] Ni Y, Yang X, Zheng L, et al. Lactobacillus and Bifidobacterium Improves Physiological Function and Cognitive Ability in Aged Mice by the Regulation of Gut Microbiota. Mol Nutr Food Res. 2019;63(22):e1900603. [4] Xiao, J., Wang, T., Xu, Y., Gu, X., Li, D., Niu, K., Wang, T., Zhao, J., Zhou, R., & Wang, H. L. (2020). Long-term probiotic intervention mitigates memory dysfunction through a novel H3K27me3-based mechanism in lead-exposed rats. Translational psychiatry, 10(1), 25.  生合生物科技有限公司Fri, 16 Oct 2020 00:00:00 GMTSynbio and Lonza Announce Exclusive Partnership of Development and Sales of Sport Probiotics TWK10® for Nutrition Markets in EU and UShttps://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=3a220430-d7dd-4d28-81b9-0e37392d954dSynbio and Lonza announce an exclusive collaboration agreement on Lactobacillus plantarum TWK10® under which Lonza will exclusively commercialize the innovative probiotic TWK10® in the US, Canada, Europe and Brazil whilst at the same time both companies will collaborate to further develop and optimize TWK10® and explore new markets and applications <img alt="" src="/ckfinder/userfiles/Images/200916-%e6%96%b0%e8%81%9e%e5%9c%96%e8%a3%bd%e4%bd%9c-LONZA%e5%90%88%e4%bd%9c_%e5%b7%a5%e4%bd%9c%e5%8d%80%e5%9f%9f%203.jpg" style="width: 100%;" /> Founded in Switzerland in 1897, Lonza is a leading global partner to the pharmaceutical, biotech and specialty ingredients markets, and is one of the leading CDMO (Contract Development and Manufacturing Organization) groups in the globe. Dr. Thomas Kiy, Vice President Strategy and Portfolio Development of Lonza commented, “We have defined Sports Nutrition &  Active Living as one of our strategic growth areas and Synbiotech's innovative TWK10® probiotic is a perfect complementation of our portfolio in this market.  We are excited to launch the first of it's kind sport probiotic product in North America and Europe very soon."  Lactobacillus plantarum TWK10®, extracted from Taiwanese Kimchi, is a research achievement with collaboration between Synbio and academics. Studies have shown that it can increase muscle endurance, improve body composition and exercise performance and reduce fatigue. Currently two human clinical papers have been published with US and Taiwan patents obtained.Moreover, TWK10® achieved US Self-affirmed GRAS on 29 May 2020, and it becomes the first certified raw material of lactic acid bacteria in local Taiwan. Dr San Lan Young, human healthcare global operation head of Synbio commented, “EU and Japan were leading the global probiotic markets for years, while now the sport probiotics TWK10® from Taiwan has attracted attention during its research and development period. Since the clinical trial was reported on Nutrients Scientific Magazine, it has been published dozens of times on international seminars and aroused more attention in scientific community. Lonza expressed its interest on TWK10® on European international probiotics seminar early 2019, two companies then started more than one year negotiation and eventually defined the collaboration direction, which has set a significant milestone to the internationalization of Taiwan’s probiotic industry.” <img alt="" src="/ckfinder/userfiles/Images/200915-%e6%96%b0%e8%81%9e%e5%9c%96%e8%a3%bd%e4%bd%9c-LONZA%e5%90%88%e4%bd%9c-TWK10%e7%94%a2%e5%93%81-%e8%8b%b1_%e5%b7%a5%e4%bd%9c%e5%8d%80%e5%9f%9f%201.jpg" style="width: 100%;" /> Mr Kuiming Li, Vice President of Human Healthcare of Synbio said, “local-developed TWK10® is one of the most remarkable sports probiotics in global market. Synbio and Lonza will leverage their respective strength on scientific research and market operation, and jointly explore TWK10®’s sports nutrition market in EU and US under the principle of win-win and mutual development. On top of cooperation with Lonza Group, Synbio will be gradually deploying its international network during 2020-2021, and we are convinced that TWK10® probiotic products will be launched soon throughout the major global markets in EU, North America, Southeast Asia, Japan, Korea and China. ”  生合生物科技有限公司Thu, 17 Sep 2020 00:00:00 GMTCriteria of microorganisms as Probiotic in food and dietary supplementshttps://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=6e60375c-9584-4dc2-9078-830202a042d5<img alt="" src="/ckfinder/userfiles/Images/60087434_L.jpg" style="width: 100%;" /> With promoting awareness of health around the world, the consumers attached highly importance to food quality and dietary supplements. More and more people maintain the state of health through dietary supplements. Several studies have reported that the gut microbiome of human is gradually affected by the metabolites, microbial characteristics, and the composition of the microbiota, which affects the physiological functions and the digestion. Probiotics are one of the beneficial microorganisms which can maintain the composition of gut microbiota, promote the absorption of nutrient and improve the immune system. With the increasing demands for dietary supplements contained probiotics, more and more importance has been attached to the quality and safety of probiotics.   Organization (WHO) and the Food and Agriculture Organization (FAO) proposed the redefinition of probiotics in 2014 which was “live microorganisms that, when administered in adequate amounts, confer a health benefit on the host”. The four following standards that determine whether microbes have qualified to be probiotics or not were reiterated in 2018 by the International Scientific Association of Probiotics and Prebiotics (ISAPP) in a position statement. Probiotic strains must be (1) sufficiently characterized; (2) safe for the intended use; (3) supported by at least one positive clinical trial conducted according to generally accepted scientific standards or as per recommendations and provisions of local/national authorities when applicable; (4) alive in the product at an efficacious dose throughout shelf life.。   (1) Sufficiently characterized. The key component of correct probiotic characterization is proper strain identification and naming. Sequencing of the 16S ribosomal DNA and whole genome sequencing (WGS) are well-known and reliable way to identified species. Through the database, the identity and the relatives with other species of stains could be confirmed.   (2) Safe for the intended use. The European Food Safety Authority (EFSA) has maintained lists of microorganisms presumed to be safe for human consumption in foods under the “Qualified Presumption of Safety” (QPS) concept as the unified risk evaluation of microbial products since 2007. The list is a basis for establishing safety of food strains when belonging to a QPS species with the strain-specific testing. Besides QPS, other countries also provide the food safety procedures to evaluate the safety of probiotics, such as “generally recognized as safe” (GRAS) of US.   (3) One positive clinical trial. In order to prevent the probiotics from safety concerns, at least one human trial demonstrating a health benefit is required to qualify the candidate microbial strains for probiotic status. Therefore, there are no major safety concerns for their use in foods and dietary supplements for the general population.   (4) Alive in the product at an efficacious dose throughout shelf life. Sufficient levels of the probiotic strains must be contained in the final product throughout the shelf life in order to be able to deliver the claimed health benefit. Products should be manufactured according to applicable good manufacturing requirements to assure safety, purity, and stability and should be labeled in a manner that communicates essential information on product contents to the end-user.   On the basis of the four criteria, specific strains of microorganisms could be qualified as a probiotic for use in foods and dietary supplements with the quality, safety and functional effectiveness confirmed. Reference: [1] Binda, S., Colin, H., Eric, J., David, O., Bruno, P., Mary, E. S., Annie, T., Arthur, C. O. (2020). Criteria to qualify microorganisms as ‘probiotic’ in foods and dietary supplements. Front. Microbiol. 11:1400. [2] Parker, C. T., Tindall, B. J., and Garrity, G. M. (2019). International Code of Nomenclature of Prokaryotes. Int. J. Syst. Evol. Microbiol. 69, S1–S111. [3] ISAPP (2018). Minimum Criteria for Probiotics [Online]. Sacramento, CA: International Scientific Association for Probiotics and Prebiotics. [4] ISAPP (2019). Probiotic Checklist: Making a Smart Selection [Online]. Sacramento, CA: International Scientific Association of Probiotics and Prebiotics.  生合生物科技有限公司Mon, 31 Aug 2020 00:00:00 GMTBio Asia-Taiwan：Thank you for your visit!https://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=11675351-8a3d-44a7-9958-b8d9be0d70a4Every year we attend this exciting show as we feel it's a great way to stay up to date with the latest industry developments and it also provides a perfect opportunity to catch up with all our national customers. <iframe allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture" allowfullscreen="" frameborder="0" height="315" src="https://www.youtube.com/embed/cqNt97iyb-E?start=3" width="560"></iframe> We would like to thank everyone who visited our stand and took the time to come and have a chat. It was great to see many familiar faces and enjoy the vibrant atmosphere of the show together. We hope you enjoyed the show and that you managed to attend our presentation to help you do the successful product. See you next year!   Please contact us for more information. we are looking forward to working together in the success of your projects.生合生物科技有限公司Tue, 28 Jul 2020 00:00:00 GMTSYNBIO TECH Business Continuity Plan for COVID-19https://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=61ee888e-8ff4-4a9a-b3a6-46dbf4df21b6In response to the challenges and uncertainties of coronavirus COVID-19, we had launched a contingency plan and measures for continuously supplying safe, healthy and high-quality probiotic products to our global customers.   Staff management The health and wellness of our employees are our number one priority, which is why we had instituted a number of guidelines and measures including monitoring temperature, establishing cleaning and disinfection procedures, restricting business trip, prohibiting customers and supplier visit, adopting necessary isolation management, establishing remote work and providing shift flexibility to ensure employees’ health and productivity.   Supply chain In accordance with our operational risk policy, we  ensured our safety stock and asked our suppliers to provide their contingency plans and health assessment plan in order to ensure our business continuity and product quality to our customer and at the same time to mitigate the effects of the virus during this period.   Social responsibility Before virus situation has been controlled, we will continually monitor the development of outbreak, strengthen employee health education program, and activate all of the safety and personal hygiene protocols and actions, while safeguarding the health and safety of all our employees and customers.   Finally, we would like to extend our deepest condolences and warm sympathy to those who suffered by coronavirus COVID-19. We hope that these damages can be restored soon. President Lian Chwan Yang  生合生物科技有限公司Mon, 30 Mar 2020 00:00:00 GMTSYNBIO TECH INC. received NSF GMP registration for supplements. https://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=2e6d123e-7864-4523-b1b2-9161d4c70dbe<div style="text-align: center;"><img alt="" src="/ckfinder/userfiles/Images/NSF.jpg" style="width: 100%;" />  </div> We are proud to announce that SYNBIO TECH INC. received NSF GMP registration for supplements. NSF certification assures suppliers, retailers, regulators and consumers that an independent organization has reviewed a product's manufacturing process and determined that the product complies with specific standards for safety, quality, sustainability or performance.  生合生物科技有限公司Wed, 27 Nov 2019 00:00:00 GMTSynbioTech Group celebrates the new factory in Yangzhou China.https://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=f555ee2e-de0a-40ad-9b8f-4e81ead8f6a3After two years of preparation and construction, SynbioTech Group has finally completed its new factory in Yangzhou, China in order to satisfy the needs of China market. On 11 April, we hold an officially grand opening ceremony and thanks to all the guests for enjoying this historical moment with us. SynbioTech Group will continue to devote into the research and development of probiotics and expand the market to provide the most competitive products.  <img alt="SynbioTech Group celebrates the new factory in Yangzhou China." src="/ckfinder/userfiles/Images/S__78364734.jpg" style="width: 100%; height: 100%;" /> <img alt="SynbioTech Group celebrates the new factory in Yangzhou China." src="/ckfinder/userfiles/Images/171326.jpg" style="width: 100%; height: 100%;" />  生合生物科技有限公司Fri, 12 Apr 2019 00:00:00 GMTSYNBIO TECH Group Celebrates Phase 2 Grand Opening https://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=1048db58-f8aa-48be-84ad-4de95dfa8f65On December 23, 2018, SYNBIO TECH Group held an opening ceremony for the phase II building expansion and new research center establishment for deepening on the application of lactic acid bacteria and gut microbiome. <img alt="" src="/ckfinder/userfiles/Images/DSC_1138.jpg" style="width: 100%; height: 100%;" /> <img alt="" src="/ckfinder/userfiles/Images/DSC_1226.jpg" style="width: 100%; height: 100%;" /> <img alt="" src="/ckfinder/userfiles/Images/DSC_1241.jpg" style="width: 100%; height: 100%;" />  生合生物科技有限公司Mon, 24 Dec 2018 00:00:00 GMTCongratulation! TWK10 wins 2018 Innovative Products Awards at Taiwan Association for Lactic Acid Bacteriahttps://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=55de571c-e8d7-47f8-b0c7-68d34a7ee67eSYNBIO TECH INC. is pleased to announce that TWK10 wins 2018 Innovative Products Awards. TWK10 is the world's first sport probiotic that can improve overall athletic performance, including increasing muscle mass, reducing fatigue, and decreasing muscle damage. We are pleased with this award – a great recognition from the probiotic professionals. <img alt="" src="/ckfinder/userfiles/Images/IMG_3051.JPG" style="width: 100%; height: 100%;" />  生合生物科技有限公司Fri, 30 Nov 2018 00:00:00 GMTAB-Kefir Probiotics wins The Annual Probiotic Industry Innovation Product Award at the 13th International Symposium on Probiotics and Healthhttps://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=b6a7674a-7880-41ae-a19a-3d5b92278566 13th International Symposium on Probiotics and Health, organized by Chinese Institute of Food Science & Technology (CIFST), was held in Guangzhou, China during May 23-24, 2018. SYNBIOTECH are delighted that AB-Kefir Probiotics wins The Annual Probiotic Industry Innovation Product Award. We developed a unique symbiotic fermentation technology, SYNTEK™ thorough, to preserve metabolites and to enhance lactic acid bacteria activity during the fermentation process and therefore AB-Kefir Probiotics to be a special product including symbiotic and postbiotic with a rich flavor. <img alt="AB-Kefir" src="/ckfinder/userfiles/Images/WeChat%20%E5%9C%96%E7%89%87_20180523101448.jpg" style="width: 100%; height: 100%;" /> <img alt="13th International Symposium on Probiotics and Health" src="/ckfinder/userfiles/Images/WeChat%20%E5%9C%96%E7%89%87_20180523101444.jpg" style="width: 100%; height: 100%;" />  生合生物科技有限公司Thu, 21 Jun 2018 00:00:00 GMTA New Strain Enhancing Exercise Performance-Lactobacillus plantarum TWK10https://www.synbiotech.com/En/ActivitiesDetailE006200.aspx?Cond=65bdda3a-e82c-437b-a32f-515237dc6752SYNBIO TECH INC. is now launching a new probiotic product TWK10 for athletes and sports consumers. TWK10, the plant-origin lactic acid bacterium, improves exercise performance by increasing muscle mass, muscle endurance and reducing fatigue. It is able to mix with proteins, BCAA, vitamins or other well-known ergogenic aids as alternative nutritional supplement for athletes or sports enthusiasts. This product will be available through partners world-wide and the first market launch is planned for the beginning of 2017.<img alt="" src="/ckfinder/userfiles/Images/170828-TWK10+ABK%E9%9B%99%E9%9D%A2DM-01.jpg" /> <img alt="Lactobacillus plantarum TWK10" src="/ckfinder/userfiles/Images/170828-TWK10%20DM.jpg" style="border-width: 1px; border-style: solid; float: left; width: 100%; height: 100%;" />  生合生物科技有限公司Wed, 08 Mar 2017 00:00:00 GMT